Report October 26, 2017 New York City Galien Forum & Prix Galien USA 2017

Cures will emerge when physician-scientists partner with pharmaceutical companies to expose and target the Achilles heel of disease. The Prix Galien rewards those at the forefront of this battle.

Michael Brown, Nobel Laureate & Professor, The sixth annual Galien Forum took place on According to Steven Pearson, President of University of Texas, Southwestern Medical Center October 26, 2017 at the Alexandria Center for the Institute for Clinical and Economic Review, Life Science in New York City, followed by the “the stimulating ferment created by bringing ~ eleventh annual Prix Galien USA Awards together the academic superstars and the The Galien Foundation Ceremony in the iconic blue-whale room of the innovative companies in attendance was a real amplifies the connection American Museum of Natural History. reminder to me of how exciting, vital, and between academia and deeply honorable the drug discovery process industry so that innovation Forum participants tackled the most pressing is. It was particularly meaningful for me to help can fulfill its potential and issues in healthcare and R&D today, and the improve the human bring the conversation about drug pricing into ceremony recognized and honored the figurative this arena.” Panelists also included Peter condition. – and occasionally literal – blood, sweat, and Bach, Director for the Center for Health Policy Olivia Flatto, President, tears that go into creating innovation to improve & Outcomes at Memorial Sloan Kettering Pershing Square Foundation the human condition. Both events welcomed a Cancer Center; Steve Miller, Senior Vice ~ star-studded list of attendees and speakers President & Chief medical Officer at Express The best of the best come to comprised of Nobel Laureates; biopharma- Scripts; Leonard Schleifer, Founder, the Galien Forum for cutting- ceutical, biotech and medical device CEOs; President, and CEO of Regeneron edge conversation about life leading researchers, scientists and Pharmaceuticals; and Stephen Ubl, President sciences R&D – innovation academicians; policymakers; and civil society and CEO of PhRMA, who called for public for human health the leaders. policies that “reward the two essential technology that supports it, elements of every life-saving treatment – and the issues that Tackling Drug Pricing and Access financial investment and time.” researchers, patients, During the Galien Forum’s keynote panel, policymakers, and life industry leaders discussed drug pricing and State-of-the-Art in Inflammation science companies are Disorders access through the lens of the Trump wrestling with. Administration. Panelists addressed gaps in the The kick-off plenary panel took a deep dive Steve Rosenberg, Senior current policy and regulatory armamentarium Vice President & General into inflammatory skin diseases and their Manager, Oracle Health that limit patient access to new medicines; mechanistic interconnections to other Sciences discussed new framework tools and inflammation disorders. Chaired by Michael ~ methodologies to evaluate the value of new Dolsten, President of Worldwide R&D for medicines against the existing standard of care; The Galien Forum and Prix Pfizer, the discussion explored how recent highlighted best industry practices to improve Galien USA events are the innovation can be applied across the Davos of life science right access and pricing; and considered new spectrum. here in Manhattan. partnering arrangements with other stakeholders. Cynthia Tsai, CEO, Healthquest

1 The successful development About Us of a new drug isn’t just a

The Prix Galien was founded in blessing to mankind; it is a France in 1970 by pharmacist demonstration that some- Roland Mehl in honor of Galen—the father of medical times, by dint of creativity, science and modern perseverance, and a bit of pharmacology. It recognizes luck, medical science can look the efforts of scientists, researchers, and companies a disease straight in the eye committed to advancing and say: Not this time. medical innovation with the power to change the human Laurie Glimcher, President & CEO, Dana condition. Farber Cancer Institute; Professor, Harvard Medical School Regarded as the Nobel Prize equivalent of biopharma- ceutical and medical technology research, the Prix With these new treatments and Founder at Alexandria Real “Why invest now? Because we Galien has been introduced come new challenges rooted in Estate Equities/Alexandria have increased our across Europe and North regulatory pathways and risk Venture Investments and Co- understanding of the biology of America and is now the most tolerance, payer acceptance, Founder of the Alexandria the blood/brain barrier. Recent prestigious award of its kind in and provider uptake, as well as Summit, and Lynn Zydowsky, advances in elucidating the 14 countries. In addition, an infrastructure needed to President and Co-Founder of the genetic associations also make International Prix Galien award leverage precision medicine Alexandria Summit and Chief this a very exciting time. is given every two years, and biomarkers, to advance Science Advisor to the CEO of Critical to success are selected from previous winners better big data approaches to Alexandria Real Estate validated biomarkers, across the globe. immuno-profiling. Addressing Equities/Alexandria Venture identifying the right patients for Investments. treatment, and proper timing of The Prix Galien USA launched these challenges requires significant time and human treatment intervention.” Jean in 2007 in New York City, Speakers examined such resources. Francois Formela, Partner at followed by the introduction of questions as what incentives are the Galien Forum. These Atlas Ventures, reminded “Health is one of the hardest – necessary to attract venture events represent a peer-to- participants to approach capital support at the key early peer exchange with a public and most important – opportunity systematically: “It purpose. Together, they businesses of all,” noted stages of product development is imperative to consider the feature unique opportunities to George Yancopoulos, and what factors these investors science, tractability of the connect with a diverse range President and Chief Scientific see as most important to target, and unmet need.” of people, organizations, and Officer of Regeneron. “We remaining engaged as funders interests, from professional must realize, as a society, that right through to receipt of a Remaining Challenges in and scientific groups, science is a long-term marketing authorization. José Cardiovascular Disease academia and governments to investment and that the Baselga, Chief Medical Officer Nobel Laureate Bengt patient associations, non-profit timeframes are very long.” for Memorial Sloan Kettering Samuelsson, renowned organizations, and the media. Panelists also included Jim Cancer Center, lauded the biochemist, former President of Kreuger from the Laboratory power of technology in making the Karolinska Institute, and The Galien Foundation’s for Investigative Dermatology such investments go farther, mandate is to foster, former Chairman of the Nobel at Rockefeller University, and faster, and ideally one day recognize, and reward Foundation, chaired a session Dan Littman, Howard Hughes helping patients to know if the excellence in scientific on atrial fibrillation, which Institute Investigator. cancer is gone for good. “New innovation to improve the state focused on novel possibilities technology,” he said, “gives us of human health. As such, a to improve quality of life and Investing in Early-Stage hope.” key pillar of the Galien process longevity in patients with the Research and Unmet is to provide communication Medical Needs most common abnormal and collaboration across Taking Alzheimer’s disease (the th cardiac rhythm. Speakers government, industry, and Addressing the challenges of 6 leading cause of death in the included Carina Blomstrӧm- academia. To that end, the investment issues was a panel United States) as a case study, Lundqvist, Professor of Galien process aligns interests on early-stage life science Ryan Watts, CEO of Denali Cardiology at Uppsala to clear direct pathways for venture capital, co-chaired by Therapeutics, sees hope and University; John Camm, productive partnerships that Joel Marcus, Chairman, CEO opportunity. steer key players across

sectors toward game-changing innovation.

2

Professor of Clinical Cardiology the standard of care for and Alfred Sandrock, This is unacceptable,” said Mark at St. George’s, University of patients – improvements that Executive Vice President and Feinberg, CEO of IAVI, “Ebola London; Jӧrg Kreuzer, helped drug researchers Chief Medical Officer at highlights models for vaccine Therapeutic Area Head at achieve greater focus in their Biogen. development and public-private Boehringer Ingelheim; Vivek work in the lab. Daryl De Vivo, partnerships that need to be reimagined.” Reddy, Professor of Cardiac Sidney Carter Professor of What’s Next in Vaccine Electrophysiology at Mt. Sinai’s Neurology and Pediatrics at Innovation? Traditional vaccines are time Icahn School of Medicine; and Columbia University Medical consuming and relatively difficult Lars Ryden, Senior Professor of Center, provided an in-depth Julie Gerberding, former to produce. Speakers explored Cardiology at the Karolinska description of the pain and Director of the U.S. Centers for new approaches like DNA-based Institute. suffering associated with the Disease Control and current vaccines, to simplify and speed

disease and the remarkable Executive Vice President, production, and novel delivery Clinical Progress in Treating recovery possible thanks to Chief Patient Officer and Head Spinal Muscular Atrophy mechanisms like cutaneous innovation, such as the first of Policy, Communications, patches, to simplify logistics and Spinal muscular atrophy (SMA) FDA-approved treatment for and Population Health at reduce vaccine hesitancy arising is a rare disease with SMA, Spinraza, whose R&D Merck & Co., chaired a panel from fear of needles. So, who widespread impact on public journey was also described focused on the development should lead the charge on this health. A dedicated panel, during the panel. and delivery of new wave costly, time-consuming, chaired by Story Landis, former innovations in vaccines in scientifically complex endeavor? Director of the National Institute Speakers also included C. preparation for the next of Neurological Diseases and Frank Bennett, Senior Vice pandemic. Vaccines are “When developing vaccines,” Stroke within the National President of Research at Ionis powerful and cost-effective explained Rajeev Venjayya, Institutes of Health (NIH) and Pharmaceuticals; Kathie public health interventions. President of Vaccines for Co-Founder of the NIH Brain Bishop, Chief Scientific Officer “Nearly 100 vaccine Takeda Pharmaceutical Initiative, recognized how at Otonomy; Adrian Krainer, compounds are now in industry Company, “companies need to awareness of the genetic roots of Professor of Molecular pipelines, targeting areas of consider relevant expertise, SMA has led to clinical trial Genetics at Cold Spring Harbor key unmet need like Zika virus manufacturing platform, potential design enhancements and a Laboratory within the Watson disease…. HIV and TB remain for impact, and commercial clinical consensus on measuring School of Biological Sciences; ever-elusive big targets….” potential. If they feel that they are going it alone and one or

Urgency persists and many more of these elements are Translating insights on how the human needed vaccines, often for missing, it’s hard to keep moving body works into health interventions that populations that cannot pay for forward rapidly, over the long- them, can present the biggest term.” can reliably help people… has always development challenges. seemed almost magical to me. Yet it is Richard Hatchett, CEO of We can’t expect vaccines to be CEPI, noted that there had developed altruistically. Public- not magic, but rather the result of been investment in vaccine private partnerships are key to demanding, relentless efforts by teams trials for a decade prior to the reduce risk; they combine of talented people. The Prix Galien USA recent Ebola epidemic. expertise and resources to reach “Nevertheless, over the course productive outcomes, quicker. allows us to celebrate those efforts and of the largest Ebola epidemic “We need ownership, not gives us all energy to strive for the next in history, it still took a year to donorship,” concluded Steven breakthrough. mobilize the products into Whitehead, Senior Associate trials. Even today, only two Scientist at the NIH National Susan Desmond-Hellmann, CEO, Bill & Melinda Gates products have established Institute for Allergies and Foundation efficacy. Infectious Diseases.

3

Prions: The New Frontier in Neurodegenerative Diseases

The final panel of the day addressed the potential of prion-based therapies in treating neurodegenerative disease, chaired by Stanley Prusiner, Professor at the University of California, San Francisco (UCSF), who received the Nobel Prize or his discovery of prions – infectious proteins that cause fatal neurodegenerative diseases in people and animals, the most famous of which is BSE (mad Honoring Relentless Efforts: The Awards cow disease) and its human form, variant CJD. The Prix Galien USA Awards recognize outstanding biomedical and technology Amanda Woerman, Assistant Professor at the product achievement that improves the human condition. The annual ceremony Institute for Neurodegenerative Diseases at represents a transformational moment each year where the monumental time and UCSF, noted that “the identification of alpha- effort that goes into innovation is recognized and honored. A star-studded crowd of synuclein as a prion in multiple system atrophy 2,000 gathered at the Natural History Museum on October 26. starts to show us that this is a mechanism that’s underlying neurodegeneration…. that will be "These products have been developed by remarkable biomedical researchers who really important for potentially developing have devoted their lives to making a difference," said Bruno Cohen, Chairman of therapeutic agents for these diseases, really the Galien Foundation. "The Committee is honored to be able to provide a forum to helping us target the actual mechanism at play recognize these outstanding achievements among a distinguished group of in a patient’s brain.” industry peers." And the 2017 winners were…

The panel featured a brain trust of other world-

renowned experts, including Marc Diamond, BEST PHARMACEUTICAL PRODUCT Director of the Center for Alzheimer’s and AbbVie and The real winners of this award are Neurodegenerative Diseases at the University of Genentech’s Venclexta, Texas Southwestern Medical Center; Roy a targeted blood cancer the patients who suffer from chronic Parker, Chair of Biochemistry at the University drug approved for a rare lymphocytic leukemia. We began this form of leukemia of Colorado at Boulder; and Eric Kandel, Fred odyssey over 20 years ago… Kavli Professor at Columbia University. Dr. Kandel received a Nobel for his research on the Jim Sullivan, Discovery Research, AbbVie physiological basis of memory storage in neurons. “Memory,” he said, “is so central to BEST BIOTECHNOLOGY PRODUCT

everything we do. Biogen and Ionis We are honored to be selected for Pharmaceuticals’ spinal View videos of each full panel here. muscular atrophy the Prix Galien for a totally new treatment, Spinraza, the technology that in a single step takes first approved drug used in treating the most a disease that was fatal and

common genetic cause catastrophic to long-term disease of infant mortality control if not cure…

Stanley Crooke, Chairman and CEO, Ionis

BEST MEDICAL TECHNOLOGY

INSIGHTEC’s Exablate This transformational technology took Neuro, the first ultrasound device to 20 years and countless efforts from have received FDA scientists and engineers to move approval for the treatment of essential from vision to fruition. Today, it tremor patients with redefines neurosurgery. We are non-invasive MR-guided focused ultrasound honored to be recognized by the Prix thalamotomy Galien.

Xen Mendelsohn Anderka, Vice President, Marketing, INSIGHTEC

4

Honoring the Humanity at the Core of Health Our annual Pro Bono Humanum The Carter Center seeks to James Greenwood, President Award was first The 2017 year's Pro Bono Humanum Award was prevent and resolve conflicts, & CEO of Biotechnology bestowed in 2007 Innovation Organization (BIO), presented to former U.S. enhance freedom and and recognizes President Jimmy Carter, Co- democracy, and improve reflected on President Carter’s Founder of The Carter Center, health worldwide. critical steps to expand innovative individual and accepted on his behalf by childhood access to and group efforts to Jason Carter, Chairman of In 2016, it reached a major immunizations as the 39th The Center. milestone with the delivery of President of the United States, improve the human 500 million doses of donated well before the astounding condition throug h The Galien Awards Committee medicines to target tropical achievements above through the application of selected President Carter as diseases in 14 African and The Carter Center. biomedical science this year's recipient stating, Latin American countries. The "President Carter follows in a Carter Center has played a “When he entered office, to problems in long line of recipients who leadership role in the elimina- immunization levels for developing or exemplify the desire for tion of river blindness, a preventable childhood excellence in pursuit of the parasitic infection, in four of the diseases had fallen to 70%. By underserved common good, and that has six Latin American countries the end of his presidency, populations always been the driving where it was endemic, and has virtually all school-aged worldwide. premise of new medical halted the disease's trans- children had been vaccinated, research. We welcome mission in several locations in and reported cases of measles Africa where more than 99 and mumps were at their More information on past President Carter and The winners can be found here. Carter Center to our roster of percent of the global cases lowest level ever. principled health leaders." exist.

2017 Prix Galien USA Awards Jury

Roy VAGELOS, M.D., Committee Chair; Retired Chairman and CEO, Merck & Co., Inc.; Chairman of the Board, Regeneron Richard AXEL, M.D., Nobel Laureate, Co-Director, the Kavli Institute for Brain Science, Columbia University Medical Center Michael S. BROWN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, University of Texas, Southwestern Medical Center Susan DESMOND-HELLMANN, M.D., M.P.H., CEO, Bill & Melinda Gates Foundation Laurie GLIMCHER, M.D., President & CEO, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School Joseph GOLDSTEIN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, University of Texas, Southwestern Medical Center Robert S. LANGER, M.D., David H. Koch Institute Professor, MIT Cato T. LAURENCIN, M.D., Ph.D. University Professor, University of Connecticut Paul A. MARKS, M.D., President Emeritus & Laboratory Head of Cell Biology, Memorial Sloan Kettering Cancer Center Rebecca RICHARDS-KORTUM, Ph.D., Professor of Bioengineering, Malcolm Gillis University Michael ROSENBLATT, M.D., Chief Medical Officer, Flagship Pioneering Bengt SAMUELSSON, M.D., Ph.D., Nobel Laureate, Former President, Karolinska institute; Former Chairman, Nobel Foundation Marc TESSIER-LAVIGNE, Ph.D., President, Stanford University

5

Galien-MedStartup Awards MEDSTARTUP JURY

Bernard POUSSOT, Director, The Prix Galien-MedStartUp program fosters cross-border research innovation between major Roche Holding; Former integrated pharmaceutical companies, biotech firms, medical device manufacturers, producers of Chairman & CEO, Wyeth vaccines, academic research institutes, and health care organizations, including e-health vendors. A focal point of the program is the active participation of innovative start-up companies outside the Roch DOLIVEUX, Ph.D., M.B.A., United States who are seeking U.S. partners to share research and support global commercial Honorary CEO, UCB development of promising lead technologies.

Mikael DOLSTEN, M.D., Ph.D., Each year the Jury nominates candidates for four awards, announced at a dynamic relationship- cultivation event that takes place at the same time as the Galien Forum, also in the Alexandria President, Global R&D, Pfizer Center for Life Science. The program boasts a track record of US$132M in funds raised to date and

60 partnerships signed from Medstartup leads. Jean-Pierre GARNIER, Ph.D., Former Global President, GSK And the 2017 winners were….

BEST COLLABORATION WITH INTRASENSE with MASSACHUSETTS GENERAL HOSPITAL and Franz HUMER, Ph.D., M.B.A., ACADEMIA LEADING TO A ZHEJIANG UNIVERSITY to create an innovative solution to Former Global President, Roche BREAKTHOUGH SOLUTION optimize treatments and ensuring reliable assessment in the management of liver cancer patients. François MAISONROUGE, M.B.A., Senior Director, BEST USE OF PATIENT QUANTUM GENOMICS with MEDPACE to elaborate a clinical Evercore Partners ENGAGEMENT TECHNOLOGIES study with hypertensive overweight patients of multiple ethnic groups in 25 hospitals in United-States.

Paul STOFFELS, M.D., BEST INNOVATIVE TRIAL PROTECSOM with ASSOCIATION PULMONAIRE DU QUEBEC Executive Vice President & DESIGN LEADING TO QUICKER and PHARMASYSTEMS to create digit’hal®, a product helping Chief Scientific Officer, Johnson BY & BETTER THERAPEUTIC patients manage their inhaled treatment. & Johnson OUTCOME

Elias ZERHOUNI, M.D., BEST COLLABORATION FOR INTEGRAGEN with THE SOLUTION LAB – US to define market President, Global R&D, Sanofi IN-DEVELOPING COUNTRIES approach for a cloud-based Software as a service solution designed to simplify the analysis of sequencing data from cancer

patients.

The work of the Galien Foundation would not be possible without the tremendous support of our sponsors and partners

PLATINUM CORPORATE LEADERS CORPORATE ASSOCIATES MEDIA PARTNERS

99 John Street Suite 2502 New York City, NY 10038 212-685-1592 www.galienfoundation.org

6

PARTICIPANTS

First Last Title Affiliation

Girish Aakalu Vice President, Global Scientific Affairs & Scientific Ipsen Bioscience Inc Intelligence

Praveen Aanur MBA Candidate Columbia Business School

Xavier Abadie International Business Development Director Sim For Health

Jeremy Abbate Vice President & Publisher Scientific American

Alexa Abdelaziz PhD Candidate Columbia University

Magdy Abdel-Malik President Quaestio Global Partners LLC

Asa Abeliovich CEO Prevail

Michael Aberman CEO Quentis Therapeutics

Amy Abernethy Chief Medical Officer Flatiron Health

Judy Absalon Senior Director Clinical Research Pfizer, Inc.

Andre Acloque Group Product Director J&J

Marlena Adamczyk Dental Student Columbia University

Katrina Adell Medical Science Liaison Spectrum Pharmaceuticals

Hervé Affagard CEO Maat Pharma

Brooke Aghajani RN, Marketing Director Gencove, Inc.

Shruti Agrawal Director Bristol-Myers Squibb

Iannis Aifantis Chair, Department of Pathology New York University School of Medicine

Praveen Akkinepally Senior Director, Marketing AstraZeneca

Said Al Qaimi pedram Alaedini President & CEO Primapax

Steven Albanese Graduate Student Gerstner Sloan Kettering

Ted Alcorn reporter The Lancet

Susan Alexander Executive Vice President, Chief Legal, Corporate Biogen Services & Secretary

Binu Alexander Executive Director Valeant

Catherine Alexis Vice President & Director of Research Triad Strategic Services

Andrea Alfano Content Developer & Communicator Cold Spring Harbor Laboratory

Jim Alfaro Senior Managing Director, Healthcare Investment Maxim Banking Peter Alff Executive in Residence Kairos Ventures

Jahan Ali Director, BD IAVI

Krishna Allamneni Executive Director, Head of Nonclinical R&D Jazz Pharmaceuticals

Rogan Allen Imagineer/VR SpaCEO; VR + 365 Music Project Florence Allouche Ghrenassia CEO Sparing Vision

Niva Almaula Head, Business Development Advanced Accelerator Applications

Zaid Al-Qaimi Chief Investment Officer Kimera

Josiane Ambiehl Department of Political Affairs United Nations

Judann Ambrose Associate Director, Marketing Biogen

Gilles Amsallem CEO ARBIOM

Querida Anderson Editor in Chief BioPharm Insight

Timothy Anderson Director Cowen Healthcare Investments

Troy Andre Senior Partner Boston Consulting Group

Stephen Andreqs CEO AboGen Inc

Beatrice Anduze-Faris BMS Medical Bristol-Myers Squibb

Dimitrios J. Angelis, Esq., Corporate & Securities Counsel Pharmaceutical Patent Attorneys, LLC

Dan-Oscar Antson Technology Licensing Officer Center for Technology Licensing at Cornell University

Humberto Antunes MD Consultant

Chris Apfel Founder & CEO SageMedic, Inc

Jeffrey Apter President Global Clinical Trials, LLC

Paul Aquilino Manager, R&D Boston Scientific

David Archer Professor of Obstetrics & Gynecology Director, Clinical Eastern Virginia Medical School; Endoceutics Research Center Ali Ardati Director, Clinical Operations Janssen

Debbie Arenare Vice President, General Counsel Cold Spring Harbor Laboratory

Daniel Arteaga MD-MBA Candidate Columbia University

Peter Arthur-Smith Founding Principal Leadership Solutions, Inc

Ernest Asante-Appiah Clinical Virology Merck & Co., Inc.

Georges Asmar Senior Vice President & Global Head of Net Lease Colony Capital, Inc. Strategy

Ewa Asmar

Can Ates CEO Ciloa

Eric Attias Investor Forepont Capital Partners

Eliene Augenbraun Managing Multimedia Editor Scientific American - Nature Publishing Group

Yimon Aye Assistant Professor Weill Cornell Medicine

Mariam Azarm Event Coordinator United Nations

Nicolas Babault Research Scientist Mount Sinai School of Medicine

Michelle Babinsky Senior Asset Services Coordinator Alexandria Real Estate Equities, Inc.

Dino Bacelic Business Consultant Financial Services TriTech Investments

Peter Bach Director, Center of Health Policy & Outcomes Memorial Sloan-Kettering Cancer Center

Chris Baer Associate Vice President, Cardiac Arrhythmia Sales Abbott

David Bagshaw Corporate Partnerships Director Springer Nature

Henri Baissas President Business France, North America

Rajesh Bajaj Vice President DF King

Sofia Bakogianni PhD Alexandria Real Estate Equities, Inc.

Ram Balani CEO Veteran Smartcare LLC

Balu Balasubramanian Managing Director Anvayah LLC

Catherine Balistreri Marketing Oracle Health Sciences

Fernando Ballesteros Innovation Director Plastibell Philip Band Professor New York University

Lisa Banket Reporter PharmaVoice

Michael Baran Senior Director Strategic Planning Pfizer, Inc.

Paul Barone Partner Freyeur & Trogue

Eliav Barr Senior Vice President, ID-Vaccines Clinical Research Merck & Co., Inc.

Clara Barreneche Executive Director Catalonia Trade & Investment

Christy Barrow Program Associate The Pershing Square Foundation

Anthony Barsotti Associate Director VL47, Inc

David Bartash Consultant Bartash

Lisa Barthelemy Senior Director, Investor Relations ACADIA Pharamaceuticals Inc

Lynn Bartner-Wiesel

Andrea Bartzen CEO Impactiv BioConsult

Helaine Baruch Chief Development Officer The Marfan Foundation

Anais Barut CEO DAMAE Medical

Jose Baselga Physician-in-Chief & Chief Medical Officer, Memorial Sloan Kettering Cancer Center, Grail, Director, Board of Directors, GRAIL, Inc. Inc

Guriqbal Basi Chief Scientific Officer, Sarepta Therapeutics Sarepta Therapeutics

Bitak Bassiri Business Strategy and New Products Ferring

Rudy Bastin Marketing Director Becton Dickinson

Isabela Batsu Senior Clinical Study Director Sanofi

Michael Batten Director JDRF T1D Fund

Michael Karl Bauer Senior Vice President, Clinical Development J&J

Richard Baxter Managing Director Hayfin Capital Management

Tyler Beatty Vice President, BD GlobalData Healthcare

Emma Becker NYC Office Coordinator Alexandria Real Estate Equities, Inc.

Camille Bedrosian Senior Vice President & Chief Medical Officer, R&D Alexion Pharmaceuticals

David Bee Director, Global Enterprise Excellence Boston Scientific

Christopher Beeckler Director, Advanced R&D J&J

Paul Beirne National Managing Director AllianceBernstein

Yvonne Bendinger-Rothschild Excecutive Director EACCNY

C.Franck Bennett Senior Vice President, Research Ionis Pharmaceuticals

Frederique Berbille CEO Neogia

Anna Berenfeld Investor Forepont Capital Partners

Jay Berfas Director Scientific American

Tomaz Berisa Co-Founder Gencove

Bill Berkrot Reporter Reuters Reuters

Lisa Berlin Vice President, Human Resources J&J

Lynda Berne Principal BAL Pharma Consulting

Stephane Bertolini Director, Project Management Pfizer, Inc.

Benjamin Bertrand CEO CardiaWave

Sonya Besagar Medical Student CUMC

David Bharucha Vice President, Clinical Development Allergan

Shelby Biagi Scientific Engagement & Communications Lead UCB, Inc.

Melissa Binz Executive Vice President, Clinical Analytics, & General Pfizer, Inc. Manager Christopher Birchard Program Director J&J Patrick J. Birde Director of Strategic Planning Gotham Biopharmaceuticals, Inc.

Kathie Bishop Chief Scientific Officer Otonomy

Kathy Bishop Chief Scientific Officer Otonomy

Paul Blake CEO Papyrus Therapeutics Inc.

Darren Blamire MSc, International Business Leader F. Hoffmann-La Roche Ltd.

Marc Blaustein CEO Ned Biosystems, Inc.

David Bleakman Vice President, Chief Scientific Officer & Neuroscience Eli Lilly & Company Site Leader, New York

Timothy Blenkinsop Assistant Professor Icahn School of Medicine at Mount Sinai

Per Blomstrom Associate Professor, Medical Science Uppsala University

Carina Blomström-Lundqvist Professor of Cardiology Uppsala University, Sweden

Darrin Blumenthal Chairman & Managing Director EverBlu Capital

Jeff Bockman Senior Vice President Defined Health

Miriam Boer Founder & Chief Scientific Officer Sonify Biosciences

Mariette Boerstoel Senior Vice President, Head Global Drug Safety Shire

Yulii Bogatyrenko Partner ATEM Capital

Natalie Bogdanov General Counsel BeCare Link LLC

Jennifer Bolton Fellow, Regulatory Affairs Boston Scientific

Anna Bondarenko Chief Operating Officer Owkin, Inc.

Pascal Borderies Senior Vice President Medical Affairs Vernalis Therapeutics

Diana Bordon Director, Regulatory Affairs Integra Life Sciences

Christine Borowski Entrepreneur-in-Residence Apple Tree Partners

Joseph Borrello PhD Student Icahn School of Medicine at Mount Sinai

Albert Bourla Group President, Pfizer Innovative Health Pfizer, Inc.

Myriam Bourla Pfizer, Inc.

Stylianos Bournazos Research Assistant Professor, Laboratory of Molecular Rockefeller University, Genetics & Immunology

Eirini Bournazou Translational Fellow Roche

Emmanuelle Bouvier President & CEO Plastibell

Victoria Bowers Associate WBB Securities

Alexandra Bowie Director, Corporate Communications Regeneron Pharmaceuticals, Inc.

Sarah Boyce CBO Ionis Pharmaceuticals

Joe Boyd CEO MCS Healthcare Public Relations

Douglas Braaten Chief Scientific Officer, publications NYAS

Kara Bradley Account Executive Finn Partners

Derek Brand Founder & CEO Quicksilver Biosystems

Jim Breault US Sales Director Nature Research

Joanna Breitstein Executive Director, Executive Communications Merck & Co., Inc

Thomas Brennan Venture Partner ARCH Venture Partners

Patricia Bricmont Bricmont Director, Pharmaceutical Development & Otsuka Commercialization

Uli Broedl Vice President, Medical & Regulatory Affairs Boehringer Ingelheim Pharmaceuticals, Inc.

Charles-Andre Brouwers Senior Partner & Managing Director Boston Consulting Group

Steve Brozak President, Managing Director WBB Securities

Doug Bruce Vice President, R&D & BDS J&J

Dana T. Bruno Managing Director DTB Capital Management Kelli Brush Project Manager Project Paladin

Charles Buchen Director, Business Development Fortress Biotech

Matt Buck Executive Director, Regulatory Affairs Ionis Pharmaceuticals

Kenneth Buckfire President & Managing Director Miller Buckfire & Co., LLC

Amelie Budry Senior COnsultant Pact & Partners

Christina Burner Elie Wiesel Foundation

Barry Burns President & CEO Gotham Biopharmaceutcials Inc

Ethan Burstein Senior Director, Biosciences ACADIA Pharmaceuticals Inc

Kyle Bushey Co-Founder & President Lyganex Bio

Ross Cagan Professor, Dept. of Cell, Developmental & Regenerative Icahn School of Medicine at Mount Sinai Biology caner Caglar Rockefeller University

John Cahill Senior Vice President JLL

Wenli Cai Assistant Professor of Radiology Massachusetts General Hospital

Andrea Califano Clyde & Helen Wu Professor of Chemical Systems Columbia University Medical Center Biology Matt Calistri Vice President, Investor Relations Biogen

Lyn Caltabiano Senior Vice President, Project and Alliance Management Merck & Co., Inc.

Stephen Caltabiano Merck & Co., Inc.

John Camm Professor of Clinical Cardiology St George’s, University of London

Joy-Maria Camm

Holly Campbell Deputy Vice President PhRMA

Jay Campbell Vice President, B.D. & I.R. Prima BioMed USA Inc.

Emma Cancelliere Consultant The Solution Lab Cancelliere Sarah Cannon Senior Account Executive Langland

Nicolas Cantatore Sales Manager Glim

Alexandra Cantley Scientist VL47, Inc

Tiffany Cao Operations Director Biosense

John Cargill Vice President, Clinical Analytics & Strategic Services Chiltern-Covance BD

Nicole Cargill Chiltern-Covance

Berit Carlson BMS Medical Bristol-Myers Squibb

Trent Carmichael Managing Principal Forester Capital

Luzelana Caro Quantitative Sciences Antivirals Merck & Co., Inc.

Jason Carter Chairman The Carter Center

Carmen Castrillo-Viguera Medical Director, Clinical Development Biogen

Charles-Edouard Catherine Executive Director Surgeons of Hope

Jessica Cerka Head of Business Development BioPharm Insight

Prin Cetuk CRA REQ

Joshua Chalif MD-PhD candidate Columbia University

Arthi Chandran Vice President & Head of Health Economics and Becton Dickinson Outcomes Research Corporate

Priya Chandran Senior Partner & Managing Director Boston Consulting Group

Stephen Chang Chairman, PhD Histogen

Stephen Chang Chairman Board Histogen

Laurent Chantalat Head of Science&Tech convergence Nestle Skin Health Jordan Chapman Director, Science & Regulatory Advocacy PhRMA

Michel Chartrain Director, Project Management Merck & Co., Inc.

Zena Chatila MD PhD Student Columbia University

Eirum Chaudhri Exec Dir, Scientific Affairs Merck & Co., Inc

Amrit Chaudhuro CEO Mass Innovation Labs

Conley Chee Vice President Global Disease Leader, Lung Novartis Pharmaceuticals

Stephane Chemouny CEO Intrasense

Yijing Chen Student Columbia University

Lillian Chen Medical Student Columbia University College of Physicians & Surgeons

Wei Chen Principal Scientist II Kadmon Corporation

Karen Chen Chief Scientific Officer SMA Foundation

Feng Chen Director - Department of Radiology The First Affiliated Hospital - Zhejiang University

James Cameron Chen

Mehdi Cheraitia CEO Neogia

Kiira Chernik Director of Business Development Alexandria Real Estate Equities, Inc.

Masha Chestukhin US Compliance Officer R&D Ind Affairs FMV Sanofi

Sherry Chi Principal Scientist Pfizer, Inc.

William Chiang Business Devlopment Mount Sinai Innovation Partners

Bill Chin Executive Vice President; Chief Medical Officer PhRMA

William Chin Chief Medical Officer & Executive Vice President PhRMA

Sadhana Chitale Director, Life Sciences/Technology Transfer New York University School of Medicine

Mike Choy Partner & Managing Director Boston Consulting Group

Lauren Chung Managing Director WestPark Capital

Ian Clark Managing Partner Dichotomy Capital

Jeff Clark Engineer J&J

Luther Clark Global Director, Scientific, Medical & Patient Pespective Merck & Co., Inc

John Cleary Partner Dentons US LLP

Michele Cleary Executive Director The Mark Foundation for Cancer Research

Cynthia Cleto Assistant Director, Marketing & Outreach Mount Sinai Innovation Partners

Anya Clifford MBA 2019 Columbia Business School

Philip Clifford CEO Sonoscanner

Gail Cohen Vice President, Corporate Communications Acorda Therapeutics

Ron Cohen President & CEO Acorda Therapeutics

Sara Cohen Strategic Programming & Events Alexandria Real Estate Equities, Inc.

Ben Cohen Director BioPharm Insight

Bruno Cohen Chairman Galien Foundation

Max Colao Senior Vice President Alexion Pharmaceuticals

Nick Colucci CEO Publicis Health

Dwayne Colvin Director of Import – Export & Vendor PPD

Benjamin Comer Manager Health Research Institute, PWC Inc

Erin Congdon Research Assistant Professor New York University School of Medicine

Alicia Conill De Vivo

Jamie P. Constantine Wealth Management, Senior Vice President Morgan Stanley Todd Cooper Senior Director, Corporate Affairs Biogen

Warren Cooper Chief Medical Officer HealthCare Royalty Partners

Peter Cope CEO TriTech Investments

Bob Coradini Adviser NMC

Stephanie Corey Associate Vice President Clinical Oncology Merck & Co., Inc

Gustavo Corral Founder Epinome

Linda Corvari President PHarm D

Christine Coudroy CEO Sonoscanner

Bernard Courtieu CEO Integragen

David Cox Vice President, Regulatory Affairs, Orthopedics & Tissue Integra Life Sciences Technologies

Russell Cox Executive Vice President & Chief Operating Officer Jazz Pharmaceuticals

Rose Crane Independent Director Teva Pharmaceuticals

Irene Crespo Business Advocate New Jersey Business Action Center

Susan E. Crinnion Executive Director Life Sciences J.P. Morgan

Jason Criscione Chief Scientific Officer Mobius Biomedical

Rosanne Crooke Vice President, Cardiology Ionis Pharmaceuticals

Stanley Crooke CEO Ionis Pharmaceuticals

Juan Cubillos-Ruiz Assistant Professor, Weill Cornell Medicine Weill Cornell Medicine

Robert Cucin CEO BioSculpture Technology, Inc.

John Cullity CBO US / Torreya Insights

Bo Cumbo Senior. Vice President, Chief Commercial Officer Sarepta Therapeutics

John Cunningham Executive Vice President Alexandria Real Estate Equities, Inc.

Francis Cuss Owner Promethean Fire LLC

Tim Czartoski Global Platform Leader, Joints J&J

Daniel Da Business Developer Manager Inoviem

Arvin Dar Assistant Professor Icahn School of Medicine at Mount Sinai

Pinaki Dasgupta Founder & CEO Hindsait, Inc.

Mark Dat President & CEO biOasis Technologies Inc.

Elena Davidson Sunovion Pharmaceuticals, Inc.

Patrick Davidson Sunovion Pharmaceuticals, Inc.

Philip J.W. Davies President, Commercial Affairs, North America Biotrial

Lee Davies Senior Vice President, Health Practice Makovsky

Steve Davis President & CEO ACADIA Pharmaceuticals Inc

Robert Davis Corporate Vice President & President, Orthopedics & Integra Life Sciences Tissue Technologies

Jordan Davis Managing Partner Radius Ventures

Steph Davis Chief Scientific Officer/ Biochemist Elke Therapeutics

Miguel De Jesus Graduate Student Sloan Kettering Institute

Philip De L'Orme President Prix Galien Netherlands

Yves de Ternay Director of Sales Navidor

Darryl De Vivo Sidney Carter Professor of Neurology & Pediatrics Columbia University Medical Center

Caren Deadorf Senior Vice President Asset Management Biogen

Gregg Dearhammer Senior Vice President Oracle

Alaric DeArment Senior Reporter BioPharm Insight

Ligia DelBianco Associate Director, Corporate Affairs Biogen Paul Dellorusso Graduate Student Columbia University

Pamela Demain Former Executive Director of Licensing Merck & Co., Inc.

Pamela Demain Board Member Prokaryotics

Valerie Demont Partner Sheppard Mullin, LLP

George Demos Executive Director, Drug Safety ACADIA Pharamaceuticals Inc

Robert Dempsey Head of Global Ophthalmology Franchise Shire

Anuj Desai Partner Futur Health Point

Sunny Desai Director of Business Transformation Saama | Life Sciences Innovation & Analytics

Chakshu Desai Manager, Global Pharmacovigilance & Risk Valeant Management.

Martial Descoutures Financial Analyst & Head of Healthcare Invest Securities

Darryl DeVivo Department of Neurology Columbia University

Alice DeVivo

Neil Dhingra Physician Mount Sinai Hospital

Melissa Diamond Senior Account Executive Informa Pharma Intelligence

Marc Diamond Director, Center for Alzheimer's & Neurodegenerative University of Texas, Southwestern Medical Disease

Karen Diedrich Senior Director of Finance Athersys Inc.

Mary Diers Manager, CardioMEMS Product Marketing Abbott

Diana Dill Senior Consultant FTI Consulting

Phil DiMassimo Account Manager Oracle Health Sciences

Mariana Dimitrova Senior Director, Biologics Drug Product & Executive Jazz Pharmaceuticals Vice Development

Aslihan Dincer Scientist Mount Sinai Medical School

Charles Henry Dion Business France Senior Manager, North American Healthare

Bryan Dirks Senior. Director, Clinical Research ACADIA Pharmaceuticals Inc

Ray Doctor Registered Nurse Mount Sinai Hospital

Catarina Dolsten Head Coach Catarina R Dolsten LLC

Mikael Dolsten President, Worldwide R&D Pfizer, Inc.

Cat Donaldson Biotechnology Program & Business Development Cold Spring Harbor Laboratory Manager

Mary Beth Dorr Infectious Disease Clinical Research Merck & Co., Inc.

Sylvain Dorriere International Sales Manager Bodycap

Jill Dosik Scientific Lead, GCI Health GCI Health

Pierre Doublet BD Invivox

Yanne Doucet Research Scientist Columbia University

Sonya Dougal Director, Life Sciences Discussion Group NYAS

Michael Draper Head of Cardiovascular External Innovation Sanofi

Steve Drehobl Merck & Co., Inc.

Craig Drill Craig Drill Capital

Eleanor Drummond Research Assistant Professor New York University School of Medicine

Julien Dubuis Director, Strategy & BD Outcome Health

Simon Ducher Senior Director, Regulatory Affairs Progenics Pharmaceuticals, Inc.

Emmanuel Dumont CEO Shade

Laura Beth Duncan Associate Director Otsuka Pharmaceutical Development & Commercialization

Peter Dunk President That's Entertainment Judith Dunn Vice President Roche Innovation Center NY

Eugene Durenard Managing Director Stetson Family Office

Yves Duroseau Chair Lenox Hill Hospital, Northwell

Cameron Durrant Chairman & CEO Humanigen

David Dworaczyk Director Life & Health Sciences Strategic Development Oracle Corporation

Toni Eardley Account Manager Oracle Health Sciences

Jay Edelberg Vice President Head of Cardiovascular Development Sanofi

Mark Edwards Assoc Dir DB Prog of Oncology Eisai Inc

Isabelle Edwards NYS Health Advocate, Producer & Host The Diabetes Diva Show

Anastasia Efthymiou Graduate Student Icahn School of Medicine at Mount Sinai

Mikala Egeblad Associate Professor Cold Spring Harbor Laboratory

Michael Ehlers Executive Vice President, R&D Biogen

Imke Ehlers Senior Licensing Manager Memorial Sloan Kettering Cancer Center

Imke Ehlers Senior Licensing Manager Memorial Sloan Kettering Cancer Center

Adi Eisenberg Vice President of Marketing Bank of America NYC.

Fritz Eisenhart President Inova

Sara Eisman Director, Program Management at Veeva Veeva

Ylva Ekdahl Postdoc New York University

Lene Ekstroem Senior Manager, Global Planning Management LEO Pharma A/S

Samir Elamrani Member Wilson Sonsini Goodrich & Rosati

Uri Elias Medical Reviewer Care To Care LLC

Bunny Ellerin Director Columbia Business School

Eileen Elliott Senior Director Leadership Pfizer, Inc.

Mary Elmer Associate Director Merck & Co., Inc

Steve Elmore Vice President, Target Enabling Science & Technology, AbbVie Discovery Research

George Elston CEO 2X Oncology

Loren Eng President SMA Foundation

Ritchie Engelhardt NY Engagement Lead Roche Innovation Center New York

Max Englander Co Founder Psocratic

Irena Erenburg Sesko Innovations

Stephanie Erjavec PHD Candidate Columbia university

Steven Eror President & CEO ProLung, Inc.

Adam Escalante Student Columbia Business School

Ian Estepan Executive Director, Corporate Affairs Sarepta Therapeutics

Alex Ettinger Student Columbia Business School

Ellen Evans Senior Director of Immunotoxicology COE Pfizer, Inc.

Sunnie Evers

Karen Eves Clinical Operations Merck & Co., Inc.

Wayne Fairbrother Senior Staff Scientist & Director, Early Discovery Gencove, Inc. Biochemistry

Olaitan Fakinlede Institutional Partnerships Manager Nature Research

Mary Fallon Analyst Triad Strategic Services

Christine Fandozzi Exec Director, Pharmacokinetics Merck & Co., Inc.

Franck Fang Vice-President, Process R&D Eisai Angel Fang Senior Global Director Opto Capital Group

Jennifer Fang Senior Associate Wilson Sonsini Goodrich & Rosati

Samir A. Farghaly Chairman & CEO FC Capital Management

Ruma Farooqui Research Support Specialist SUNY

Wildon Farwell Senior Director, Clinical Development Biogen

Jad Fayad Product Manager GE Healtcare

Mark Feinberg CEO IAVI

David Feldman Portfolio Manager L1 Capital Global Inc

Indra Felice Manager Theaprin Pharmaceuticals Inc

Philip V. Felice President & CEO, Chief Medical Officer, Co-Inventor Theaprin Pharmaceuticals Inc

Michel Feraud CEO Provepharm

Surani Fernando Editor BioPharm Insight

David Ferrero R&D Operations Allergan

Andy Ferrin Strategic Accounts, Clinical & Drug Safety Oracle Health Sciences

Jean-François Fevre Global R&D Partnerships Manager Plant Advanced Technologies Mark Fielding Director, Medical Writing Biogen

Owen Fields Vice President, Global Regulatory Strategy Inflammation Pfizer, Inc. & Immunology

Dr. David Filer Biotechnology Consultant Sunrise Equity Partners

Kiko Filipov Analyst Future of Surgery Advisors

Jacqueline Fine Merck & Co., Inc

Richard Finkel Division Neurology Dpet Pediatrics Nemours Children's Hospital

Terri Finkel

Mark Finkelstein National Sales Director PharmaSystems

Tyler Finn Vaccines Clinical Operations Merck & Co., Inc

Virginia Fisher Portfolio Operations Manager, EGFR Astra Zeneca

Debbie Fisher Executive Director, Global Clinical Development Merck & Co., Inc

Lesley Fishman Senior Director, Investor Relations J&J

Julien Fiszman Chief Marketing Officer MyBrain Technologies

Brendan Fitzpatrick Vice President, Enstilar TaskForce LEO Laboratories Ltd.

Martina Flammer Vice President, CDMA - Specialty Care Boehringer Ingelheim Pharmaceuticals, Inc.

Mark Flanagan Associate Research Fellow, Applied Synthetic Pfizer, Inc. Techologies

Olivia Flatto President, Co-Founder & Executive Director, The Pershing Square Foundation Pershing Square Sohn Cancer Research Alliance

Ruth Fleming Vice President, Marketing, Orthopedics & Tissue Integra Life Sciences Technologies

Laurent Flouret Director, Global Digital Strategy & Innovation Sanofi

Jenna Foger Senior Principal, Science & Technology Alexandria Venture Investments

Ori Foger Alexandria Venture Investments

Olivier Fontaine Head, International Affairs Medicen

Jean Francois Formela Partner Atlas Ventures

Richard Foster Principal Biostatistician Biogen

Stephen Foxworth Associate Director, Business Development QuintilesIMS

Marc Frahm Vice President, Equity Research Cowen & Company

Alexandre Fraichard Excecutive Director & CEO Genoway

Fred Frank Chairman Evolution Life Science Partners Lee Fraser Senior Vice President, Science & Medicine Digitas Health

Kenneth C. Frazier Chairman & CEO Merck & Co., Inc.

Andrea Frazier

Alan Frederickson Senior Director, Product Development QuintilesIMS

Leonard Freedman President Global Biological Standards Institute

Christopher Frenz Senior Business Development Manager Mount Sinai Innovation Partners

Martin Friedman Principal Pharmakon Advisors

Phyllis Frosst Director, Public Health Policy Seqirus

Pierre Frouin President & CEO Bioserenity

Pierre E Ftekhari President Inoviem

David Fuchs Managing Partner B&P Management

Alex Fudukidis Vice President Russo Partners

Niuska Fuenmayor Nurse Lutepal

Les Funtleyder Healthcare Portfolio Manager E Squared Asset Management

Gale Funtleyder

Marina Furmanov Director of Lab Operations Alexandria Real Estate Equities, Inc.

Peter Fusco Partner, Technology Companies Group Orrick, Herrington & Sutcliffe LLP

Mariano Gabitto Researcher Columbia University

Ashley Gaines Head, Women's Cancer Marketing AstraZeneca

William Gaines Portfolio Manager Lexington Capital Management

Moti Gal Senior Business Development Manager NovellusDx

Susan Galbraith Vice President, INM AstraZeneca

Michael Galiano Graduate Student Gerstner Sloan Kettering Graduate School of Biomedical Sciences

James Galione Marketing Novartis Pharmaceuticals

Claire Gallagher Director Corporate Relations NYAS

Dominick Gallo Vice President, Medical Operations Henry Schein Medical

Wolf Gallwitz Chief Scientific Officer Discovery Worldwide

Ankur Gandhi Senior Manager, Research & Development, Product Integra Life Sciences Development

Matthew Gantz CEO OxThera Inc

Rui Gao PhD Student Gerstner Sloan Kettering School of Biomedical Sciences

Gabriel Garcia Dental Student Columbia University

Silvia Garcia Codony CEO EternoGen

Patrice Garnier CEO Amabiotics

Patricia Garrison Director Communications WEBMD

Tina Garyantes Vice President, Therapeutics Chromocell

Sylvain Gauthier Patents Manager Endoceutics

Evripidis Gavathiotis Associate Professor Albert Einstein College of Medicine

Alina Gavrilova Principal Navita

Robyn Gay Global CV Communications Sanofi

Manuel Gea CEO BMSystems

Richard Geary Senior Vice President, Development Ionis Phrmaceuticals

Kurt Geitz Vice President, R&D Boston Scientific

Vanessa Gelman Director, WRD Communications Pfizer, Inc. Vinu George Director Otsuka Pharmaceutical Development & Commercialization

David Georges Senior Vice President, Sales & Marketing Koning Corporation

Julie Louise Gerberding Executive Vice-President, Chief Patient Officer & Head Merck & Co., Inc. of Policy, Communications, and Population Health

Yves Germani Business France Health International Network Business France

Shari Gersten Advisory Board Member Galien Foundation

Jyotsna Ghai Ghai Vice President R&D BIOSURGERY J&J

Sarah Ghosh Executive MBA Columbia Business School

Ananda Ghosh Technology Marketing Associate New York University

Shubhalok Ghosh CEO NewCo

Sarah Ghuens Senior Director, Clinical Development Biogen

Ryan Gibson Global Clinical Supplies Project Manager PPD

David Giddings Corporate Adviser GII

Haim Gil-Ad CEO Novellux DX

Aaron Gilchrist Global Director Bridge to Life

Kathy Gilligan Editor PM360

Jean-François Ginglinger Head of PAT research Plant Advanced Technologies

Daniel Gipe Senior Director, Clinical Sciences - Cardiovascular & Regeneron Pharmaceuticals, Inc. Metabolism

Tim Girton Vice President, R&D Boston Scientific

Barbara Gladson As. Dean & Director of Biopharma Rutgers School of Health Professions

Izzy Gladstone Marketing Director eyeforpharma

Richard D Glaser President Benchmark Communications, Inc.

Fraser Glickman Director Rockefeller University

Moshe Gluzman Chairman Peter Sheehan Diabetes Care Foundation

Carsten Goessl Indication Lead, GMD AstraZeneca

Laura Goetz MD-PhD Student Columbia University

Brian Goff Chief Commercial Officer Alexion Pharmaceuticals

Mark Goldberger Cardiologist New York University School of Medicine

Arleen Goldenberg Director, Product & Pipeline Communications Regeneron Pharmaceuticals, Inc.

Abram Goldfinger Executive Director, Industrial Liaison/Tech Transfer New York University

Mark Goldstone Managing Partner Freyeur & Trogue

Hugo Gomes da Silva Vice President GMA, Head of Metabolics Alexion Pharmaceuticals

Karen Gomez MD-PhD Student Columbia University College of Physicians and Surgeons

Braulio Gomez Valades Medical Director Novartis Pharmaceuticals

Fernando Goni Research Associate Professor New York University Langone Health Dept Neurology

Renata Gontijo Lima Clinical Reserach Medical Director Novartis Pharmaceuticals

Dr. Irene Gonzalez President & CEO Novodux

Joshua Goodman MD-PhD Student Columbia University College of P&S

Olivia Goodman Vice President Finn Partners

Gary Gordon Vice President of oncology development AbbVie

Isabelle M Gorrillot Business Development and Licensing Director Mount Sinai Innovation Partners

Cynthia Goss Director Patient Adovcacy Regeneron Pharmaceuticals, Inc.

Carter Gould Biotech Analyst UBS Assaf Govari Vice President,WW Advanced R&D J&J

Akankasha Goyal Physician New York University Langone Medical Center

Lynda Graham CFO Kinder Pharm

Craig Granowitz Senior Vice President, CMO Amarin Pharma, Inc.

Lars Granstrand Swedish TV

Charles Gray Director, Innovation Sourcing Novo Nordisk

William O. Gray, III Partner Ostrolenk Faber LLP

Helen Green Account Director Langland

Cynthia Green Senior Director, Worldwide Business Development Pfizer, Inc.

James C. Greenwood President & CEO Biotechnology Innovation Organization

Tina Greenwood

Giana Gregga Associate Vice President Finn Partners

Jacqueline Gress Director, Clinical Operations Merck & Co., Inc.

Brendan Grier Business Development Manager Nature Research

Christophe Grignon Head of Invest Dept (US Office) Business France / French Embassy

Marc Grodman Assistant Professor Columbia University

Marc Grodman CEO Genosity

Taren Grom Co-Founder/Editor PharmaVOICE

William Gruber Senior Vice President, Vaccine Clinical Research & Pfizer, Inc. Development Rama Gudivada Principal Analyst, Statistical Programming Biogen

Patrick Guinn Guinn Director, OPDC Otsuka Pharmaceutical Development & Commercialization

Timur Güngör Director Research Collaborations Bristol-Myers Squibb

Grace Guo research analyst Bloomberg

Gaurav Gupta Private Equity OrbiMed Advisors

Dayla Guris Clinical Research Merck & Co., Inc.

Carlos Gutierrez Vice President Strategy & Insights Healthcare Univision Communications

Emma Guttman

Pascal Guy CEO Robocath

Nicolas Guyon-Gellin Enyo Pharma

Kimberly Ha Senior Director FTI Consulting

Pascal Hadjedj Primary Markets Sales & Syndication Invest Securities

Michael Halem Data Scientist BeCare Link LLC

Catherine Hall Director of Operational Excellence Sunovion Pharmaceuticals, Inc.

Victor Halpert Fund manager Hudson East Capital

Jonathan Hamilton Vice President, Public Affairs Abbott

Dane Hamilton US Healthcare Editor Mergermarket Group

Pat Hanley Private Equity Weild & Co

Reza Haque Vice President, Medical Affairs Shire

Michael Harbour Global Executive Director, Infectious Diseases Merck & Co., Inc

Ed Harnaga Vice President, Communications, WRD Pfizer, Inc.

Eliot Harrison President MCS

Ridge Hartley Private Equity Weild & Co

Bill Hartman Executive Vice President Cushman & Wakefield, Inc.

Irfan Hasan Program Director, Health & Behavioral Health The New York Community Trust John Hatcher Vice President of Business Development Accessium Group, Inc.

Richard Hatchett CEO CEPI

Leslie Hawley Executive Director, Pharmaceutical Sciences Lead for Pfizer, Inc. Inflammation & Immunology

Pavan Heda Global Head, Strategy & Portfolio Operations J&J

Sara Hedlund

William Heiden CEO AMAG

Jeff Heilbraun Vice President, Strategy Development, Medical Imaging Bioclinica & Biomarker

Dan Heller Deputy Director, The Wistar Institute Cancer Center Memorial Sloan Kettering Cancer Center

Timothy Hemesath Director of Biotherapeutics Pfizer, Inc.

Tracy Henrikson Associate Vice President, Communications Eli Lilly & Company

Matt Herper Reporter Forbes

Guillermo Herrera Guest Merck & Co., Inc.

Vivian Herrera Executive Director, Head Immunology & Dermatology, Novartis Pharmaceuticals Neuroscience and Ophthalmology, and Payer Strategy

Orin Herskowitz Executive Director Columbia Technology Ventures

Evan Hicks Director, Marketing AstraZeneca

Vincent Hillenmeyer CEO H4D

Mikhail Hitune Principal Madison Square Capital LLC

Mary Hobart Senior. Director, OPDC Otsuka Pharmaceutical Development & Commercialization

Kenneth Hobby President Cure SMA

Michael Hochstat Managing director WBB Securities

Gerard Honig Transational Research Manager Crohn's & Colitis Foundation

Valere Horath CEO Quipment Inc

Sean Hosp Executive Director, Market Access Merck & Co., Inc

Michael Hotra Vice President, Public Affairs PhRMA

François Hourcastagnou President Phyto

Brandy Houser Site Head NY/NJ Celdara Medical

Brad Hover Associate Director Lodo Therapeutics Corporation

Kelly Howell Scientist SMA Foundation

Helen Hoxie Research Assistant Intra-Cellular Therapies, Inc

Helen Hsia Guset of Richard Hsia Guset of Richard Hsia

Richard Hsia Senior Director, CTM Management Sunovion Pharmaceuticals, Inc.

Naiyun Hsu Postdoc Mount Sinai School of Medicine

Xinli Hu Manager, I&I Human Genetics, Genome Sciences & Pfizer, Inc. Technologies

Yun-Han Huang MD-PhD Student Memorial Sloan Kettering Cancer Center

Joublin Hugues Global Head of Corporate Affiars AstraZeneca

Robin Hume Senior Director, Global Regulatory Strategy Jazz Pharmaceuticals

Rod Humerickhouse Group Project Leader, Oncology Development AbbVIe

Kathryn Humphrey Principal Clinical Development Scientist, Roche Hematology/Oncology

Andres Hurtado-Lorenzo Director of Translational Research Crohn's and Colitis Foundation

Daniyal Hussain Associate Vice President Columbia Business School - HCIA Nouhad Husseini Husseini Vice President of Business Development Regeneron Pharmaceuticals, Inc.

Charlotte Huyton Account Director Langland

Christina Hwang Reporter BioPharm Insight

Peggy Hwang Biostatistics Merck & Co., Inc.

Sarah Hymowitz Vice President, Protein Chemistry & Structural Biology, Gencove, Inc. Genentech Research & Early Development

Jeanette Ilett Product Operations Lead Shire

Ron Ingram Vice President, Product Development Integra Life Sciences

Doug Ingram President Sarepta Therapeutics

Muhannad Irmeileh International Product Manager F. Hoffmann-La Roche Ltd. Irmeileh Alicia Irurzun Lafitte Principal, Healthcare Merck Ventures

Bob Iseniorael Vice President of Clinical & Medical Affairs Valeant

Jean Sebastien Jacquetin Senior Director Citic Hyperion

Linda Jahnke Manager, Program Management Boston Scientific

Manasi Jain Chief Innovation Officer AboGen Inc

Vishal Jain Partner Freyeur & Trogue

Sumayah Jamal CEO ENB Therapeutics, LLC

Mohammed Jamal Portfolio Manager Forepont Capital Partners

Jijo James Chief Medical Officer J&J

Hanuman Jampani Global Franchise Growth Leader, Orthopedica & Tissue Integra Life Sciences Technologies

Marion Janic Rooney Partners

Kathrin Jansen Senior Vice President & Head, Vaccine R&D Pfizer, Inc.

Irene Jarchum Senior Editor Nature Biotechnology

Brook Jennings PHarm D

Hal Jensen

Mona Jhaveri Director Sound Affects

Robert John Division Vice President, Heart Failure Abbott

William Johnson Managing Partner Boler Biotech Consulting

Brett Johnson Managing Partner - US China BioVentures

Brett R. Johnson Founder & CEO OneMedMarket

Michael Johnson CEO & Co-Founder Visikol Inc

Laura Johnston

Pascal Joncour Managing Director Argon Global Healthcare

Hugues Joublin Head of Global Corporate Affairs Oncology AstraZeneca

Beth Joy-Dougherty Global Franchise Lead, Wound Reconstruction & Care, Integra Life Sciences Orthopedics & Tissue Technologies

Ross Julian Analyst InnovaHealth Partners

Daniel Jung Research Coordinator Project Paladin

Sung Jung Hwan Principal Boston Consulting Group

Christa Justus Chief Grants Management & Communications Officer Mark Foundation for Cancer Research

Thomas Kaczur President CN-Eximus, Inc.

Austin Kaidi Editor DISTLD Media

Ahsanul Kaiser PhD Scholar Monash University Malaysia

Greg Kaluza Director, Operations CRF Skirball Center for Innovation

Denise Kandel Medical Sociologist Columbia University Eric Kandel Nobel Laureate, Professor and Fred Kavli Professor, Columbia University, New York Department of Neuroscience

Shin Kang Vice President, Head of Research HealthCare Royalty Partners

Marc Karako CFO Quantum Genomics

Tomer Kariv Managing Partner Pontifax

Michael Karlin CEO Ibex Biosciences

Rashida Karmali CEO Tactical Therapeutics, Inc

Armand Karpinski Associate, External Innovation Sanofi

Nicholas Kartsonis Vice President, Clinical Research Merck & Co., Inc.

Steven Karuppan CEO & Co-Founder Blinded Diagnostics

Amanda Kasper Research Scientist New York University

Ilona Kats Graduate Student New York University

Nataliya Katsnelson Senior Manager, Busiess Development Global Clinical Trials, LLC

L. Brian Katz Surgeon Laparoscopic Surgical Center of New York

John Kauwe Department Chair, Bioinformatics Brigham Young University

Marcia Kayath Head, US Clinical Development & Medical Affairs Novartis Pharmaceuticals

Yuyong Ke Director, Analytical Technology Endoceutics

Maureen Keegan-Renner Head of Project Management Nestle Skin Health SHIELD

Jacqueline Keith president J Keith Consulting

Harvey Kellman Managing Director Wind River Partners

Christian Kelly Vice President, Quality Assurance Integra Life Sciences

Brian Kelly, Director of the CTL office in NYC Weill Cornell

Lisa Kent CEO Illumination

Yasmin Khan Quipment Inc

Nadia Khoso Student Columbia Business School

Anne Khuong Orbimed

Chau Khuong Private Equity Partner Orbimed

Konstadinos Kidos Vice President, Global Drug Safety Operations Shire

Dan Killian President Harvard Investors Group

Millie Killic CEO Damae Medical

Iain Kilty Vice President, I&I Preclinical Research Pfizer, Inc.

Seaho Kim Postdoctoral Research Associate Weill Cornell Medicine

Moritz Kircher Assistant Member Memorial Sloan Kettering Cancer Center

Kim Kjoeller Executive Vice President, Global R&D LEO Pharma A/S

Kristen Klasey Director, Global Oncology Communications Novartis Pharmaceuticals

Udo Klein Project Team Leader, Portfolio Management & Gencove, Inc. Operations, Genentech Research & Early Development Scott Klien Director, Heart Failure Global Marketing Abbott

Roland Knoblauch Clinical Leader J&J

Stephen Knowles Partner Knowles Partners

Robert Knowles Business Development Pfizer, Inc.

Michael Kobluchar Senior Vice President, Portfolio Strategy & Analytics Pfizer, Inc.

Joan Koeber-Walker CEO Arizona Bio

Sheldon Koenig Senior Vice President & Global Head CV Franchise Sanofi

Natalija Koreka Senior Manager Strategy- Healthcare Univision

Nedialko Kostov United Nations

Paul Koulogeorge Merck & Co., Inc.

Laura Kovanda Astellas Pharma

Don Kraft Senior Vice President, Human Resources Icon Plc

Adrian R. Krainer St Giles Foundation Professor of Molecular Biology Cold Spring Harbor Laboratory, Watson School of Biological Sciences

Merrill M. Kraines Partner Pepper Hamilton LLP

Daniella Kranjac Founder, Managing Director Dynamk Capital

Mario Kranjac General Counsel Dynamk Capital

Heather Krasna Dean, Career Services, School of Public Health Columbia University

Susan Krauss President & Co-Founder Green Corsair Tech Labs Global TM

Rivka Kreitman Senior Vice President. Head of Search and Evaluation Teva Pharmaceuticals

Jörg Kreuzer Therapeutic Area Head Medicine CV Boehringer Ingelheim Pharma GmbH & Co. KG

Shiv Krishnan Head, BD&L-Technology Platforms Sanofi

Jim Krueger Laboratory for Investigative Dermatology, Rockefeller Rockefeller University University

Martin Krusin Vice President, Finance & Business Development AzurRx BioPharma, Inc.

Praveen Kudithipudi Senior Vice President, Healthcare Investment Banking WestPark Capital

Kristie Kuhl Senior Partner Finn Partners

Ravi Kumar CEO ARKAY Therpaeutics

Seema Kumar Senior Vice President of Innovation, Global Health, and Johnson & Johnson Policy Communication

Neeraj Kumar Executive Director Ksoft

Winston Kung Vice President BD & Global Alliances Celgene

Larry Kunstadt, PhD CEO Enhanced Pharmaceuticals, Inc.

Anthony Kurda Senior Life Sciences Saama Technologies

William Kuziel Director Daiichi Sankyo Group

Constantinos Kyprianou Business Development manager Informa Pharma Intelligence

Fernand Labrie CEO Endoceutics

Nicole Labrie Endoceutics

Bernard Lachapelle President Prix Galien Canada

Francois LaFleur Vice President, Medical Affairs Helsinn

Trammy Lai Healthcare Analyst E Squared Capital

Arnaud Lambert CEO AllCare

Kelly Lambrinos Senior Editorial Analyst BioPharm Insight

Louise Lammers Associate Director, Drug Discovery Institute, Icahn Mount SInai School of Medicine

Russell LaMontagne President Boston Immune Technologies and Therapeutics, Inc.

Story Landis Co-Founder, NIH BRAIN Initiative & Former Director National Institute of Neurological Disorders and Stroke, National Institutes of Health

Charles LaPree Senior Vice President, Global Regulatory Affairs Jazz Pharmaceuticals

Ellen Lapriore Global Vice President of Support & Services Oracle Health Sciences

Marc Lara Chief Scientist Microhealth

Kristin Larson NP Manager of Clinical Research & Training Prolung Jack Laschever Executive Vice President Springer Nature

Thomas C Lauda Retired pharma executive Schering-Plough

Daniel Laune CEO Kyomed

Diva Lauren Chairman Diva Lauren

Cato T. Laurencin Professor Institute for Regenerative Engineering

Cynthia Laurencin

Telemaque Lavidas CEO Lavipharm

Géraldine Le CEO NH Theraguix

Bertrand Le Conte De Poly CEO LLTech

Martin Leach Vice President, R&D and Global Operations IT Alexion Pharmaceuticals

Howard Leavitt Partner Vector Capital Associates

Thierry Leclerc Operation Lead BioLabs

Didier Leclercq Managing Director Nestle Skin Health - SHIELD

Lilly Lee Portfolio Manager Aurora Asset Research

L Veronica Lee Vice President Sanofi

Anne-Claire Legendre Consul of France French Consulate

Peter Leger Partner MDPRESS

Pablo Legoretta CEO Royalty Pharma

Frederic Legros COO Dynacure

Daniel Leibovici

Jerome Leleu CEO SimFor Health / Interaction Health

Morgane LeMellay CEO Robocath Thomas Leonard Executive Director, Therapeutic Area, CDMA Boehringer Ingelheim Pharmaceuticals, Inc.

Frank Leu CEO Novapeutics LLC

Amy Levasseur Supervisor, R&D Boston Scientific

Joel Leverson Scientific Director, Oncology Development AbbVie

Pavel Levin President & CEO Vaposun Inc.

Peter Levinson Founder LevinsonBlock Healthcare Marketing

Sally Levinson PhD Candidate New York University Neuroscience

Scott Levitt Senior Associate Pharmakon Advisors

Tzachi Levy Project Manager J&J

Henry Levy Chief Strategy Officer Veeva

Greg Lewis Global Client Leader Publicis Health

Tim Ley Manager, R&D Boston Scientific

Weimin Li Biomarker Leader J&J

Zhong Li Sunovion Pharmaceuticals, Inc.

Zhenrui Liao MD-PhD candidate Columbia University

Jeffrey A. Lieberman Chair Department Psychiatry Columbia University

Baihan Lin PhD Student Columbia University

Yan Lin Faculty New York University School of Medicine

Marianne Lind Senior Scientist, Exploratory Formulation & LEO Pharma A/S Technologies

Bosse Lindquist Swedish TV

Luna Lioue Business Manager New York University Medical Center

Richard Lipkin Managing Director Easton Capital

Charisse Litchman Medical Advisor BeCare Link LLC Dan Littman Investigator, Howard Hughes Medical Institute Kimmel Skirball Institute of Biomolecular Medicine Professor of Molecular Immunology

Yan Liu Founder Forward Clinical Soultions

Goerge Llado CIO Alexion Pharmaceuticals

Gerard Llanos Research Fellow R&D J&J

Ginny Llobell Senior Vice President Defined Health

George Lloyd Executive Vice President, Investments & General Royalty Pharma Counsel

Ellen Locker Exec Dir, Strategic Alliances Merck & Co., Inc

Nick Loizos Research Advisor Eli Lilly and Company

Catherine London Executive Vice President, Corporate Communications & biOasis Technologies Inc. Investor Relations

William Looney Executive Director In Vivo

Dr. Monica Lopez Co-Founder and Scientific & Artistic Director La Petite Noiseuse Productions

Jean-Christophe Lourme CEO Valotec

Patrick Loustau CEO Zumbro Discovery, Inc.

Ken Loveday Director, PreClinical Saftey Biogen

Ellen Lubman Vice President Allergan

Dominick Lucci CIO Park Ave. Capital Management

Monica Luchi Self

Steve Ludmerer Clinical Virology Merck & Co., Inc.

Dale Ludwig Chief Scientific Officer-Biologics Technology Eli Lilly & Company

Xenia Luna Scientist Kadmon Corporation, LLC

Dane Lund Postdoctoral Research Fellow Memorial Sloan Kettering Cancer Center

Jan Lundberg Executive Vice & President-Sci/Tech Eli Lilly & Company

Hieu Ly Vice President, Integrated Data Services Eisai Corp

Yana Lyhkman Advisor Vaxeal

Ssally Lynch Vice President General American Investors Company, Inc.

Olga Lyudovyk Student Columbia University

Frank Ma Medical Student Columbia University Medical Center

Yue Ma Student New York University Biology

Z. Alex Ma CEO Pegasus Bio

Gregory Macaraeg Sanofi

Sonia Maccioni Group Product Director J&J

Laurie MacDonald Merck Regulatory Merck & Co., Inc

David L. Macdonald Co-Founder, President & CEO Veramarx

Chioma Madubata MD-PhD Candidate Columbia University

Thomas Magaldi Manager, Career and Professional Development Memorial Sloan Kettering Cancer Center

Agata Magalinskaya Operations & Events Alexandria LaunchLabs

Chris Maggos Managing Director, Europe LifeSci Advisors

Alex Magid Partner Magid Family Office plc

Mahmoud Mahmoudian Vice President, Head of Innovative Medicines Purdue Pharma

Pooja Majmudar Business Development Mgr New York University

Susan Malenbaum Associate Director, Immunology Medical Affairs Boehringer Ingelheim

Richard Maletta Director , Marketing Novartis Pharmaceuticals

Shaheen Malick Medical Student Columbia University Mathai Mammen R&D Chief Johnson & Johnson

Kristina Man R&D, Clinical Programs Shire

Eugene Mancino Partner Mancino Burfield Edgerton

Ya-El Mandel-Portnoy Founder & CEO Cardea Sciences

Jiten Manglani Director, Social Investment The Pershing Square Foundation

William Mann CEO Helsinn

Susan Manoff Executive Director Merck & Co., Inc

Edoardo Marcora Associate Professor Icahn School of Medicine at Mount Sinai

Joel S. Marcus Chairman, CEO & Founder Alexandria Real Estate Equities, Inc.

Barbara Marcus

Dawn Margolis Aurora Capital

Jeff Margolis President Aurora Capital

Jeff Margolis Senior Vice President & CFO RespireRx Pharmaceuticals

Michael Mark Vice President, Global Head Cardio-Metabolic Diseases Boehringer Ingelheim Pharmaceuticals, Inc.

Andrew Marshall Chief Editor Nature Biotechnology

Celine Martel Director, Data Analysis & Regulatory Affairs Endoceutics

Michael Martin Consultant Klinical Strategy Consultants

Jason Martin Corporate Vice President PAREXEL

Amy Martini President Martini Consulting

Jason Martini Corporate Vice President, Global Data Operations Parexel stella Martomo Principal Scientist I Kadmon Corporation, LLC

Rogowski Mary Director, Business Development Voluntis

April Mascia Associate Director, Clinical Trial Materials Management Sunovion Pharmaceuticals, Inc.

Henry Mascia

Henry Maslowski Investor & Vice President A.C. Blinder Corp

Dominique Massie Executive Director Quebec Lung Association - Association Pulmonaire du Quebec

Alan Mateo Executive Vice President Global Sales. Veeva

Sharon Mates Chairman & CEO Intra-Cellular Therapies

George Mathew Chief Medical Officer DXC Technology

Hiroshi Matsuura Senior Research Scientist Mitsubishi Tanabe Pharma Holdings America, Inc. Jyrki Mattila Executive Vice President Business Development Recro Pharma

Russell Maus Director, Global Project & Alliance Management Merck & Co., Inc

Frederick Maxfield Professor and Chair of Biochemistry Weill Cornell Medical College

Kapil Mayawala Director Merck & Co., Inc.

Stefanie Mazlish CEO TSL: The Solution Lab

Zehra Mazur Scientist AMNH

Kathryn McAllister Director, Business Development Amgen

David McCallen Partner Piccolo Advisory

Alex McCampbell Principal Investigator, Research Biogen

Michael McCann Vice President North America Sales Oracle Health Sciences

Dennis McCarthy President BodyCap USA, Inc.

John Mccauley Director Chemistry Merck & Co., Inc.

Ian McConnell Exec Dir, Global Communications Merck & Co., Inc. Raj McIntyre Social Worker NY-Presbyterian Hospital

Paul McKenzie Executive Vice President, Pharmaceutical Operations & Biogen Technology

Tom McKenzie Managing Partner Cavendish Global

Astrid McKeown Senior Principal Clinical Scientist AstraZeneca

Sarah McMahon Global Molecule Lead Jazz Pharmaceuticals

Chris McManners International Development Manager RDI

Henry McNamara Vice President of Sales Oracle Health Sciences

Fiona McPhee Research Fellow Bristol-Myers Squibb

Andrew Meadow General Partner Excelyrate Capital

Kelly Mehrer Director, Connected dExecutive Vices QuintilesIMS

Jaime Melendez Director, Emerging Technology Partnership & Innovation Johnson & Johnson

Dave Melin Founder & Principal Innovation Partners, LLC.

Jessica Melore Motivational Speaker Oracle Health Sciences

Genevieve Menard Managing Director Menard Solutions

Xen Mendelsohn Aderka Vice President of Marketing INSIGHTEC

Andrea Meoli Chief Commercial Officer HELSINN Healthcare

Fred Mermelstein Managing Director Ascentia Asset Management

Allison Merrick Managing Principal Merrick Advisors

Darin Messina Vice President, Tissue Materials Sciences Allergan

Reema Mewar LifeCycle Leader Venetoclax Global Product Strategy, Gencove, Inc. Genentech

Bruce Meyers Managing Director Meyers Investments

Josef Michl Founder & Chief Scientific Officer NomoCan Pharmaceuticals

Martha Millard Acorda Therapeutics

Tim W. Miller President & CEO Echelon-Frontier Scientific

Steve Miller Senior Vice President & Chief Medical Officer Express Scripts

John Miller Vice President, Global Products Jazz Pharmaceuticals

Kristine Miranda Co Founder Psocratic

Hala Mirza Vice President of Corporate Communications & Regeneron Pharmaceuticals, Inc. Citizenship

Christopher Missling President & CEO Anavex Life Sciences

Leslie Mitchell Chief Scientific Officer Neochromosome, Inc.

Tim Mitchell Chief Medical Officer Saatchi & Saatchi Wellness

Faical Miyara Vice President Kadmon Corporation

Mehrdad Mobasher Global Development Team Lead, Product Development Gencove, Inc. Oncology, Genentech

Corentin Moevus PhD Student Columbia University

Jo Mohr Principal BioAsset Advisors LLC

Leybis Molina Guest of Mark Edwards Eisai Inc

Michael Monahan Senior. Director, Regulatory Affairs ACADIA Pharamaceuticals Inc

Annemarie Monschein Registered Financial Advisor New York Life

Rick Monsma Senior Vice & President, Scientific Operations The New York Stem Cell Foundation

Michael Montello Vice President, Head of R&D Solutions IT QuintilesIMS

Jean-Christophe Montigny Biophytis CEO

Seung Hyun Moon Senior Director, U.S. Marketing Alexion Pharmaceuticals Jennifer Moore Vice President Communications Cellectis

Elizabeth Moore Quantum Genomics

David Moore Manager, Veeva Vault Veeva

Rene Morales Acorda Therapeutics

Peter Morcos Senior Clinical Scientist F. Hoffmann-La Roche Ltd.

Rick Morelli Account Manager Oracle Health Sciences

Paula Morgan Principal Aveus

Deborah Morosini Board member Bonnie Addario Lung Cancer Foundation

Gary Morris Senior Manager Drug Development Allergan

Chelsea Morris Associate Rethink Impact

Richard Moscicki Executive Vice President PhRMA

Arikha Moses Founder Galatea Surgical

Audrey Mosley Director of Clinical Operations Merck & Co., Inc

Manana Mosoian Private Banker First Republic Bank

Arevik Mosoian Chief Scientific Officer SkinAxis LLC

Valerie Motti International Development CCI Grand Est

Andre Moura MD NMC

Hubert Mouret President HDJ Advisor

Raymond Mui Managing Director Ascentia Asset Management

Bibhash Mukhopadhyay Principal NEA

Joe Muldoon CEO Fast Biomedical

Brian Mulnix Vice President, Marketing LEO Pharma Inc.

Kurt Munson Vice President of Business Development Symphony Health

Monica Murphy Marketing Novartis Pharmaceuticals

James Murray Partner ExSight Ventures

Anthony Muslin Vice President, Head of Cardiovascular & Fibrosis Sanofi Therapeutic Strategic Unit

Alain Mutschler Vice President Operations, North America Plastibell

Christopher Mutz Vice President, US Metabolic Business Unit Lead Alexion Pharmaceuticals

Denise Myshko Managing Director PharmaVoice

Frederic Naayem Analyst NYM

Simardeep Nagyal Student Columbia University

Rajeev Nair CEO KRIS Capital

Jeffrey Nau CEO Oyster Point Pharmaceuticals paul navarre CEO Ferrhing

Elisa Navarro Postdoctoral Fellow Mount Sinai

Fred F. Nazem Chairman & CEO Rejuvenan Global Health

Mark Nelson Vice President Business Development Echelon-Frontier Scientific

Michael Nelson CEO Intrommune Therapeutics

Charles Nelson Physician Murdock Capital

Christian Neumann Executive Vice President & COO Provepharm

Melanie Nyuydzefe Scientist Kadmon Corporation, LLC

Roger Newton Senior Vice President Esperion

Roger Newton Director Esperion

Ha Nguyen Senior Director Biostatics Pfizer, Inc. Lisa Niemela Manager, Internal Communications, Orthopedics & Integra Life Sciences Tissue Technologies

Monica Nieves Marketing Manager, Womens Cancer Astra Zeneca

Pascal Nigen Managing Partner Alpha Bronze

Didier Nimal CEO Osseomatrix

Lutao Ning COO Koning Corporation

Ruola Ning CEO Koning Corporation

Vic Noble Vice President & Head of Marketing - Ophthalmics Shire

Mark Noe Vice President, Groton Center of Chemistry Pfizer, Inc.

John Nolan Portfolio Manager WBB Asset Management

Waseem Noor Senior Vice President Russel Reynolds

Michael Norsen Head of Business Operations & Strategic Planning, RGC Regeneron Pharmaceuticals, Inc.

Michael Nova Chief Innovation Officer Pathway Genomics

Stephanie Noviello Clinical Program Lead, Virology Bristol-Myers Squibb

David Novotny Senior Vice President, MD&D Novella Clinical

Catherine Nuccio Associate Alexandria Venture Investments

Jeff Nugent CEO Sientra

Luke Nunnelly PhD Student CUMC

Lieven Nuyttens CEO & Founder Tri-Medix, LLC

Margaretta Nyilas Senior Vice President, Pharmaceutical Development & Otsuka Commercialization

Judit Nyirady Vice President, Medical Strategy & Scientific Affairs LEO Pharma Inc.

Joe Oakley Senior Medical Advisor Eli Lilly and Company

Lisa Oatway Partner MDPRESS

Katie O'Brien Executive Director- Corporate Communications and Alexandria Real Estate Equities, Inc. Special Projects

Michael O'Brien President, Clinical Trials AMC Health

Atsuo Ochi Assist. Professor New York University MC

Sean O'Connell Partner McKinsey

Beth Odeh-Frikert Global Disease Area Director Roche Genentech

Shane O'Donohoe Rare Disease Group Mgmt Biogen

Lydia Ogden Associate Vice President Enterprise Policy Merck & Co., Inc.

David Olsen Discovery Biology Merck & Co., Inc.

Paul O'Neill Managing Director inVentiv Health

Norihisa Onozawa MBA, President & CEO, Chugai Pharma USA

John Orloff Executive Vice President, R&D Alexion Pharmaceuticals

Vishnu Oruganti College of Medicine

Bridget Osetinsky Co Founder & CEO Hyperfine

Christopher O'Toole Managing Partner Nine TZ Healthcare Ventures

Guillaume Ouinas International Development Director CCI Normandie

J. Randall Owen Senior Vice President & Chief Medical Officer ACADIA Pharmaceuticals Inc

Michael Paas Vice President Market Access & Pricing Regeneron Pharmaceuticals, Inc.

Neal Padte COO RenBio, Inc.

Stella Paffenholz PhD Student Memorial Sloan Kettering Cancer Center

Christina Pagano President Pagano & Company Public Relations Leif Pagrotsky Consul General Swedish Consulate in New York

Gene Panasenko Vault Manager Financial Advisor Moloney Sec-RVC

Pratik Pangaonkar Strategic Alliance Manager BioPharm Insight

Asit Panja Chief Scientific Officer AlfaGene BioScience, Inc.

Erini Papapetrou Associate Professor, Icahn School of Medicine Mount Sinai

John Pappadakis Account Manager Oracle Health Sciences

Justin Paquette Director, Public Affairs Abbott

Trilok Parekh Senior Director R&D J&J

Jason Park CEO VL47, Inc

Michael Parker Director Galien Foundation

Roy Parker Professor Cech-Leinwand Endowed Chair of University of Colorado Biochemistry

Madison Parks Associate Researcher Mount Sinai School of Medicine

Lynne Parshall COO Ionis Pharmaceuticals

Chiraag Patel Chief Medical Officer Chimeron Bio Corporation

Kinnari Patel Senior Vice President, Global Program Team lead Rocket Pharma Ltd

Troy Patterson Associate Vice President, Heart Failure Sales Abbott

Brice Paulik CEO Views by Marie Claire Group Company

Sergey Paushkin Director, Research SMA Foundation

Sara Pawley Senior Director, IT QuintilesIMS

Serge Payeur CEO Sil Lab

Jeff Payne CEO Grid Networks Systems

Dr.Raj Pazhiannur President Keystone Corporation

Steve Pearson Founder & President Institute for Clinical and Economic Review (ICER)

Alison Pedley Biostatistics Merck & Co., Inc.

Sylvie Peltier Senior Director, Search Evaluation & Due Diligence Teva Pharmaceuticals

Mark Penniston Executive Vice President, Clinical Analytics, and Chiltern-Covance General Manager

Marc Pentopoulos Partnet Vista Point Capital

Roland Peralta Nutrafol Nutraceutical Wellness Inc

Marina Peredo CEO Peredo MD

Vladimir Perez-Camillo

Stephen Perl Vice President, Senior Investment Advisor Calamos

Bradley (Scott) Perrin R&D Business Technology Pfizer, Inc.

Lauren Peters Head, Disease Discovery Sema4 Genomics

Sharon Peterson Executive Director & President Montana BioScience Alliance

Timothy Peters-Strickland Senior Director, Global Clinical Development Otsuka Pharmaceutical Development & Commercialization

Michael Petroutsas Head Oncology Breast Marketing Novartis Pharmaceuticals

Sergei Petukhov Pertner Enso Ventures

Alexis Peyroles COO / Operations, Finance & BD OSE Immunotherapeutics

Zachary Pfauth Head of Clinical Operations Valeant

Stephanie Pfister Director, Clinical Mgmt Otsuka Pharmaceutical Development & Commercialization

Sephy Philip Senior Director, Medical Affairs Amarin Pharma, Inc

Cintia Piccina Vice President, Lung & Rare Diseases Franchise Novartis Pharmaceuticals Joseph Pickrell CEO Gencove, Inc.

Eric Pierce Publisher BioCentury

Vanessa Pierce Director BioCentury

Michel Pignatiello Assoc Dir Corporate Counsel Regeneron Pharmaceuticals, Inc.

Derek Pike Sanofi

Emmanuelle Pina Client Services Manager Hereva

Sandrine Piret-Gerard Vice President, Head-Solid Tumor Franchise Novartis Pharmaceuticals

Julie Pitrat Senior Trade Advisor Business France

Ruth Plager President ZenithBIO daniel Plants MD Voce Capital

Greg Plowman Vice President, Oncology Research Eli Lilly and Company

Vincent Poher CEO Avalun

Mark Pohl Business Development Pharmaceutical Patent Attorneys

Robert B. Polak President Polak Associates michael Polakov CEO medi build

Pam Polino Executive Director, Scientific Affairs Merck & Co., Inc.

Victoria Pollosson Trade advisor Business France

Marissa Poock Elie Wiesel Foundation

Mina Popat Elie Wiesel Foundation

Bob Pordy Vice President Clinical Sciences Cardiovascular & Regeneron Pharmaceuticals, Inc. Metabolism

Thierry Poree CEO ProtecSom-OptimHal

Christopher Posner Executive Vice President, Region US LEO Pharma Inc.

Tracey Potter MD-PhD Candidate Columbia College of Physicians & Surgeons

Andrew Powaleny Director of Public Affairs PhRMA

Masha Poyurovsky Kadmon Corporation, LLC

Alex Preker Investor Healthcare Investment & Financing

Frank Prendergast Director of Product Category Henry Schein Medical

Bruce Press Executive Vice President, Commercial Operations Seven Bridges.

Samiyeh Price Global Medical Affairs Director J&J

Leslie Prichep Chief Scientific Officer BrainScope Company, Inc.

Jeffrey Priest CEO General American Investors

Stanley Prusiner Chair, Nobel Laureate, Professor of Neurology and UCSF Biochemistry

Michele Przypyszny Vice President, Principal Gifts The New York Academy of Sciences

Elizabeth Punnoose Biomarker Oncology, Senior Scientist Gencove, Inc.

Mark Punyanitya Co-Founder, President, & CEO PhenoMx, Inc.

Dinesh Puppala Director, Scientific Affairs Pfizer, Inc.

Dennis Purcell Founder & Senior Advisor Aisling Capital LLC

Maurice Quaglieri Global Regulatory Lead J&J

Sabrina Quagliozzi Press Member BFMTV rana quraishi Director, New Ventures University of Maryland Baltimore

Alison Racine PharmD Glaxo-SmithKline

Eric Racine Vice President, North America Public Affairs Sanofi

Eric Racine Vice President & Head, NA Public Affairs Sanofi

Sidrah Rafiq Translational Medicine Fellow Chimeron Bio Govind Ragupathi Immunologist Memorial Sloan Kettering Cancer Center

Joya Raha Business Development Director Business France

Divya Raj MBA-MPH Candidate Columbia Business School

Towfique Raj Assistant Professor Icahn School of Medicine at Mount Sinai

Jay Rajda Chief Clinical Transformation Officer Aetna

Mahmoud Ramadan Assoc Director, GIL, Global Onc, Mktg GPS Lung Novartis Pharmaceuticals

Kumar Ramamoorthy Regional Marketing Director Novartis Pharmaceuticals

Satesh Ramdhani Post Doctoral Fellow Mount Sinai

Priyanka Ramesh PhD Candidate New York University

Vincent Ramoutar Founder & CEO uConekt Inc.

Lydia Ramsey Reporter Business Insider

Andrew Rankin Regeneron Pharmaceuticals, Inc.

Cliff Ransom Executive Director, Partnerships & Customs Media Nature Research Group

Arash Raofuinia Raofuinia - Senior Director, OPDC Otsuka Pharmaceutical Development & Commercialization Zachary Rapp Co-Founder & Coo PhenoMx, Inc.

Gregory Raskin Vice President, Technology Development Memorial Sloan Kettering Cancer Center

Shilpa Rastogi Director of Medical Affairs Valeant

Frank Rauscher Deputy Director The Wistar Institute

Isabelle Raux Director, ADVS Business France

Nell Rebowe Director of Business Development Anavex Life Sciences

Yocelyn Recinos Graduate Student Columbia University

Tianle Redanz Associate Director of Business Development Mitsubishi Tanabe Pharma Holdings America, Inc.

Kaitlyn Reddan Sales Consultant- Life Science TriTech Investments

Vivek Reddy Professor Medicine Cardiology Mount Sina Hospital New York

Jen Redmond

John Reed Global Head of Pharma Research & Early Development Roche

Marcia Reefer President Excelolife LLC

Karen Reeves President & Chief Medical Officer AZTherapies

Ruth Reeves Toxicology Lead Shire

Shruta Rege Director, Regulatory Affairs Shire

Alton Reich CEO Vital Metrix

Julie Remy Business Developer Biotrial

Julie Remy Business Development Director Biotrial

Anthony Renodon Business Developer Associate Cambridge BioLabs

Sandy Reyna Associate Medical Director, Clinical Development Biogen

Deirdre Ricaurte MD-PhD Student Columbia University

Whitney Richards Founder & Executive Chairman Veramarx

Miles Richardson PhD Student Columbia University

Mary Richardson Communications Leader, R&D Innovation J&J

Ron Richeter

John Rigaut Managing Director JTR & Associates, LLC

DAria Rile Analyst Altacap

Michael Ringel Senior Partner and Managing Director Boston Consulting Group Laurence Riot Lamotte CFO Integragen

Tom Rising Associate Director, Value & Access, Rare Biogen

Elsa Rive Galien Med'Startup - Senior Trade Advisor Business France

MaryAnne Rizk Vice President, Global CRO Partner Business Oracle Health Sciences

Carlo Rizzuto Partner Versant Ventures, Inc.

Michael Robertson Clinical Research - HCV Merck & Co., Inc.

Jon Rockoff Reporter Wall Street Journal Wall Street Journal

Braceras Rogelio Executive Director, Therapeutic Area, CDMA Boehringer Ingelheim Pharmaceuticals, Inc.

Aurelie Roger Trade Advisor Business France

Michelle Roh Student Columbia University

Robert Rollins Associate Director, Oncology Therapeutics Discovery Pfizer, Inc.

Jean-Loup Romet-Lemone Senior advisor Institut Pasteur

Jean-Loup Romet-Lemonne Executive Chairman VitamFero

Ze'ev Ronai Co-Director Technion Integrative Cancer Center

Steve Roon Senior Vice President SageMedic Inc

Steve Rosenberg Senior Vice President and General Manager Oracle Health Sciences

Michael Rosenblatt Chief Medical Officer Flagship Pioneering

Patty Rosenblatt

James Rosener Marketing Associate EACCNY

Dan Rosenstein Financial Advisor Morgan Stanley

Tom Rosenwald Buffkin Group

Adrian Ross CEO Beagle Bioscience

Sergio Rossi Partner and Managing Director Boston Consulting Group

Jody Roth Advisor-COO Eli Lilly and Company

Melvin Rothberg CEO Rothberg Associates

Mace Rothenberg Senior Vice President & Chief Development Officer- Pfizer, Inc. Oncology

Dan Rothman CIO Roivant

Donna Rounds Managing Director/ Innovation Hospital for Special Surgery

Olivier Roy Assistant to the President Endoceutics

Larry Rubin CEO & Co-Chair BeCare Link LLC

Bruce Rubin Jessie Ball DuPont Distinguished Professor & Chair, Virginia Commonwealth University Department of Pediatrics

Christopher Rucas Director, Communications The Michael J.Fox Foundation

Shamim Ruff Senior Vice President, Regulatory Affairs & Quality Sarepta Therapeutics

Edward Ruiz PhD Student Columbia University

Sharon Rutter Senior Director, Fund of Funds Empire State Development Corp

Barbara Ryan Founder Barbara Ryan Advisors

John Ryan Executive-Vice President, Chief Medical Officer Kadmon Corporation, LLC

Britt Ryden

Lars Rydén Senior Professor of Cardiology Karolinska Institute Stockholm, Sweden

Tierney Saccavino Executive Vice President, Corporate Communications Acorda Therapeutics

Rachel Saffitz Senior Manager, Reputation Communications Pfizer, Inc.

Olivier Safir CEO Pact & Partner

Susan Salomon CEO & Co-Founder New York Stem Cell Foundation Erwan Salque Director of Innovation Pharmagest

Ed Saltus Director-Regulatorhy Eli Lilly & Company

Tarek Samad Head of Neurodegeneration Pfizer, Inc.

Laila Samady-Mustad Vice President Global Genomucs Group

Deepak Sampath Principal Scientist, Translational Oncology, Genentech Gencove, Inc. Research & Early Development

Bengt Samuelsson Nobel Laureate, Former President of Karolinska Institute Karolinska Institute Stockholm, Sweden & Former Chairman of the Nobel Foundation

Karin Samuelsson

Manisha Samy Biotech Analyst Ark Invest

Raymond Sanchez Senior Vice President, Global Clinical Development Otsuka Pharmaceutical Development & Commercialization

Robert Sanchez Senior Director Health Economics & Outcomes Regeneron Pharmaceuticals, Inc. Research

Clare Sanders Strategic Advisor Valotec

Joel Sandler Associate Principal Defined Health

Gilian Sandler

Alfred Sandrock Executive Vice-President and Chief Medical Officer Biogen

Erica Sandrock HR Partner Biogen

David Santangelo Counsel Pepper Hamilton LLP

James Sapirstein CEO Contravir Pharmaceuticals

Aradhana Sarin Citi Group in NYC

Eric Sarrazin CEO Surg-up

Kathryn Sasser Global Marketing Director Boston Consulting Group

Rohan Satishkumar Program Manager Becton Dickinson

Michele Sausser Vaccines Clinical Operations Merck & Co., Inc

Michael Sauter Senior Director, Regulatory and Global Labelling. Mallinckrodt

Robert Schaffer Partner SAABOA

Philippe Schaison BOD Sientra

Elizabeth Schaison

Gerard Schaison

Jordan Schecter Senior Director Clinical Research J&J

Zev Scherl Chief Commercial Officer Inception

Michael Schindelar Associate Director, Clinical Program Leadership Biogen

Leonard Schleifer Founder, President & CEO Regeneron Pharmaceuticals, Inc.

Valerie Schlub Strategic Advisor Drexel University College of Medicine

Monica Schmiede Senior Account Executive Informa Pharma Intelligence

Eugene Schneider Vice President, Clinical Development Ionis Pharmaceuticals

Henrieta Scholtzova Research Assistant Professor New York University School of Medicine

Marc Schorpion Vice President, Human Resources J&J

Sarah Schroeder Partner DiRaimondo & Schroeder LLP

Kurt Schwab Student Columbia Business School

Jeffrey Schwartz MD Bain Capital

Eileen Schwartz Manager Pfizer, Inc.

Jonathan Schwartz CMO Rocket Pharma Ltd

Gina Schweizer Schweizer Associate Director R&D J&J Rob Scott Vice President, Development AbbVie

Soraya Scroggins MD Barclays

Youssef Sebban

Laure Sebi Managing Director Protravel

Liliana Secareanu CEO Lenox Hill Advisers

Thomas Seck Vice President, Clinical Development and Medical Boehringer Ingelheim Pharmaceuticals, Inc. Affairs - Primary Care

Ross Segan CMO, Medical DExecutive Vices, Global Medical Affairs J&J

Lionel Segard President & CEO Quantum Genomics

Jennifer Seibert General Manager GAP Ventures

Lillian Seidman Davis CIO Avixa Capital

Richard Serbin COO The Gorlin Companies

Dan Seto Managing Director SternAegis Ventures

Salim Shah President Sarfez Pharmaceuticals Inc

Hemanshu Shah Vice President, Corporate Development & Medical Transgene Affairs

Nilufer Shaikh Partner Pepper Hamilton

Dov Shamir President Simpel and Associates

Pirouz Shamszad Senior Medical Director Quantum Genomics

Peter Shapiro Director GlobalData

Tara Sharif CEO Tarachon

Austin Shaw Graduate Student Columbia Business School

Tora Shea Account Director Langland

Kate Shelton Account Manager Oracle Health Sciences

Max Shen Student Columbia University

Wei Fei Shen Student Columbia University

Yiqin Shen Senior Reporter Healthcare & US-Asia Cross-border

Emily Sheridan Vice President, Strategic Programming & Philanthropy Alexandria Real Estate Equities, Inc.

Dhanuraj Shetty Senior Director Strategic Alliances and Partnerships The New York Stem Cell Foundation

Michael Shichor CEO Shichor Publishing Ltd.

David Shields Executive Director Pfizer CTI

Susan Shiff Senior Vice President, Quantitative Sciences Merck & Co., Inc.

Anna Shmelkova Reseacher Mount Sinai Hospital

Leigh Shocrylas Senior Manager, Operations Excellence - GCD Sunovion Pharmaceuticals, Inc.

Amir Shojaei Vice President, Ophthalmology TA Head Shire

Boris Shor CEO M-BIO

Jian Shu CEO Indevcor

Jian Shu Venture Partner Legend Capital

Lorraine Shui Director Novartis Pharmaceuticals

Vadim Shulman Professor at the Brain and Mind Research Institute and Weill Cornell Medical College, Cornell University the Department of Neurology

Kristina Shulman

Alison Shurell Head of Health Sciences Marketing Oracle Health Sciences

Sergei Sibirtsev Business Development Azoft Inc.

Clement Sicard CEO La Valériane Sherry Siegel Director, Medical Affairs, Neurosurgery Division Integra Life Sciences

Einar Sigurdsson Professor New York University School of Medicine

Jennifer Silvent Senior Vice President MCS

Laurie Silver CFO BrainScope Company, Inc.

Robert A Silverman Roche Partner Roche Silverman Ed Silverman Pharmalot Columnist Stat

Greg Simon President Biden Cancer Initiative

Francoise Simon Professor Emeritus - Health Policy and Management Columbia University

Shuan Sims Reporter BioPharm Insight

Michael Singer CEO BrainScope Company, Inc.

Dinakar Singh Chairman of the Board SMA Foundation

Ajay Singh Managing Director UBS

Martin Siwak CTO JSenior LIFE SCIENCE

Jonathan Skipper Executive Director of Technology Development Ludwig Institute for Cancer Research Ltd.

Aleksandar Skuban Global Head, Medical Safety Otsuka Pharmaceutical Development & Commercialization

Michele Skupp Prinicpal Oracle Health Sciences

Timur Slonim IP Strategist Mintz Levin

Julianne Smith Vice President Translational Sciences Cellectis

Evan Smith Managing Director FTI consulting

Robert Smith Founder Investment Community Visibility

Karen Smith Executive Vice President, Head of Global R&D, Chief Jazz Pharmaceuticals Medical Officer Lori Smith Co-Founder LSadvantage Group Inc.

Heind Smith Vice President, USCDMA Oncology Clinical Operations Novartis Pharmaceuticals

Norman Smith Director of Payer Research Research America, Inc.

Barry Smith MD, PhD President & CEO The Rogosin Institute

Ryan Smolkin Graduate Student Gerstner Sloan Kettering

Yaniv Sneor Co-Founder Mid Atlantic Bio Angels

Megan Sniecinski Senior Vice President Business Operations and PTC Therapeutics. Program Management

Nay Soe CEO Angany Genetics

Morten Sogaard Vice President, WRD Genome Sciences & Technology Pfizer, Inc.

Ibrahim Soifoine Principal KCM

Joel Solar Managing Director Franklin Global Partners

Doug Solomon Barclays

Susan L. Solomon CEO NYSCF

Danni Song Project Director Biosense

Marcio Souza COO PTC Therapeutics

David Spector Director of Research Cold Spring Hrbor Laboratory

Brett Spector CEO Fesarius Therapeutics Inc.

Kate Spencer Managing Partner Langland

Kathy Spencer-Pike Vice President, V&A Sanofi

Robert Spiegel President Spiegel Consulting

Bryan Spielman Advisory Board Member Galien Foundation Avi Spier Director, Search and Evaluation, NIBR BD&L Novartis Pharmaceuticals

Thijs Spoor CEO AzurRx BioPharma, Inc.

Robert Spurr Vice President, Patient Solutions & Access, Oncology Novartis Pharmaceuticals

Murali Srivathsa Divisional Vice President, Global Heart Failure Abbott Marketing

Donnette Staas Regulatory Liaison Merck & Co., Inc.

Matt Stack CFO Koning Corporation

Scott Stallings Senior Director, Global Marketing Alexion Pharmaceuticals

Lou Stancato Research Fellow Eli Lilly and Company

Serge Stankovic Executive Vice President & Head of R&D ACADIA Pharmaceuticals Inc

Larry Starke Associate Vice President Regulatory CMC Eli Lilly & Company

John Staropoli Associate Medical Director, Clinical Development Biogen

Catherine Stehman-Breen Senior Vice President & Chief Medical Officer, Sarepta Therapeutics, Inc. Stehman-Breen Robert Stein Advisor Agenus

Sotirios Stergiopoulos Senior Vice President & Head of Global Medical Affairs Ipsen

Jordan Stern CEO Blue Sleep

Lilian Stern CEO Stern Investor Relations

Perry Sternberg Head, US Commercial Shire

Blake Stevens General Manager Alexandria LaunchLabs

Cathy Stevens Executive Director, Translational Medicine Merck & Co., Inc

Erin Steward Senior Manager Allergan

Bruce Stillman President & CEO Cold Spring Harbor Laboratory

Paul Stoffels Executive Vice President & Chief Scientific Officer Johnson & Johnson

Katelijne Stoffels

Ache Ezer Stokelman Akitek Solution

Robert Stoklosa Senior Equity Analyst Bifrost Capital

Gretta Stone Deputy Vice President PhRMA

Ben Strain Director, Investor Relations Biogen

Michael Strand CEO ImmunoRestoration, Inc

Jim Streeter Vice President, Product Strategy Oracle Health Sciences

Per Stromhaug As Vice President for Innovation and Economic Binghamton University, SUNY Development

Lisa Strovink Chief Strategy Officer NYSCF

John Strumbos Senior Healthcare Analyst Weiss Multi-Strategy Advisers

Ayyappan Subbiah Founder & CEO Sevengenes

Michael Suesserman Vice President, Marketing Regeneron Pharmaceuticals, Inc.

Haru Sugino Director Otsuka Pharmaceutical Development & Commercialization, Inc.

Jim Sullivan Vice President, Discovery AbbVie

Jopseh Sum Director, Research EcoR1 Capital

Peng Sun Director, Biostatistics Biogen

Anthony Sun Zeno Pharmaceuticals

Jung Hwan Sung Principal Boston Consulting Group

Ekaterina Surovick Director, Payer Research Research America

Elisabeth Svensson Senior Vice President DIA George Symalis CEO The IQ Group

Lawrence Tamarkin President & CEO CytImmune Sciences, Inc.

Paul Tamburri Senior Clinical Scientist Roche

Zhi Xu Tan Regional Director, New York Office Singapore Economic Development Board

Sharon Tang Managing Director Harvard Investors Group, Inc

Masumi Taniguchi Associate Director Novartis Pharmaceuticals

Mary Tanner Senior Managing Director Evolution Life Science Partners

William Tappe Global Development Lead Jazz Pharmaceuticals

Rolf Taylor Vice President, Partnerships HealthUnlocked

Seth Taylor CFO Mass Innovation Labs

Kalahn Taylor-Clark Associate Vice President & Head, US Public Affairs, Sanofi Cardiovascular Unit

Julia TCW Postdoctoral Fellow Icahn School of Medicine at Mount Sinai

Fabian Tenenbaum CEO Bellerophon Therapeutics

Daniel Teper CEO Cytovia

Jo Terrell Portfolio Manager TW Asset Management

Andrew Tershakovec Clinical Research Merck & Co., Inc

Remy Tessou Business Consultant Syadem / MesVaccins.net

Gowthamee Thangavel Postdoctoral Fellow Icahn School of Medicine at Mount Sinai

Marie Thibault Managing Editor Medical DExecutive Vice & Diagnostic Industry

Leonard Thomas Executive Director, Therapeutic Area, CDMA Boehringer Ingelheim Pharmaceuticals, Inc.

Brian Thomas Lab Manager/ Senior Scientist Highline Therapeutics

Nigel Thompson Partner Parks Pharma Consulting LLC

Nancy Thornberry CEO Kallyope

Kim Tien Regional Account Manager, Hypophosphatasia Alexion Pharmaceuticals

Mike Tillinger Senior Director, Clinical Affairs MNK

Jeanene Timberlake RooneyPartners LLC

Robert Tipping Director, Biostatistics Merck & Co., Inc.

Meg Tirrell Reporter NBCUniversal

Patrick Tobin Senior Designer Alexandria Real Estate Equities, Inc.

Martin Tolar Founder, President & CEO Alzheon

Peter Tollman Senior Partner & Managing Director Boston Consulting Group

Adriana Toma Houel Inward Investment Advisor Life Sciences Aderly

Kira Tomlinson Student Columbia University

Dominic Tong NSF I-Corps Advisor UC San Diego

Claire Topal Managing Director Red Tomato Consulting

David Toung Senior Analyst Argus Research

Olivia Tournay Flatto President The Pershing Square Foundation

Stephan Toutain Board Member Targeted Cancer Therapeutics

Natalie Touzet Vice President JLL

Adam Townsend Senior Vice President, Specialty Medicines Group Biogen

Megan Tran R&D Business Technology Pfizer, Inc.

Sheldon Traube Director of Investment Research Kareg Investment

Isaac Treitel Director MedPro Investors

Sofia Trepp Anna Tretiakova Vice President, Rare Disease Research Unit Pfizer, Inc.

Lloyd Trotman Professor Cold Spring Harbor Laboratory

Christopher Troy Medical Student Columbia University

Anne Troy Consultant FTI Consulting

Cynthia Tsai CEO Healthquest

Aileen Tsai Principal Pharminent LLC

Giorgos Tsetis Co-Founder & CEO, Nutrafol Nutraceutical Wellness Inc

Maria Tsingas Intern Associate BioPharMatrix LLC

John Tuddenham Medical Student Columbia University

Roland Turck Managing Partner TurckBio

Biance Turetsky

Stephen Ubl President & CEO PhRMA

Evan Udine Associate Researcher Mount Sinai

Michelle Umali Postdoctoral Fellow Icahn School of Medicine at Mount Sinai

Granville Ungerleider Managing Member & President NSIP LLC

Samik Upadhaya PhD Candidate Columbia University

Ashok Upadhyay Global R&D IT Leader Otsuka Pharmaceutical Development & Commercialization Marshall Urist Vice President, Research & Investments Royalty Pharma

Misti Ushio CEO TARA Biosystems

P. Roy Vagelos Chairman Galien Awards Committee

Diana Vagelos

Manasi Vaidya Reporter BioPharm Insight

Vishal Vaidya Global Biomarkers Lab Lead Pfizer, Inc.

Renu Vaish Associate Vice President Regulatory Merck & Co., Inc

Emma Van Hook Director, Policy & Research PhRMA

Joanne Van Ryn Senior Medical Advisor Boehringer Ingelheim Pharma GmbH & Co.KG

Deborah Vanderheyden Managing Director JLL

Marvin Vasquez Digital Marleting Director MMUSA

Maria Vazquez Business Development Director Gencove

Stanislas Veillet CEO Biophytis

Rajeev Venkayya President, Global Vaccine Business Unit Takeda

Claudia Verdes MBA Candidate Columbia Business School

Jean Emmanuel Vernay CEO Invest Securities

Lynne Verselis Clinical Scientist Hoffmann-La Roche, Inc

Jane Vesotsky Senior Director, Lung Cancer Marketing Novartis Pharmaceuticals

Eric Vieira Director CUNY

Kirsten Viering Engineer, R&D Boston Scientific

Simona Vigna Freelance Journalist Radio Montecarlo

Emma Vinarsky Chief Innovation Officer Aleph Capital

Baldassare Vinti Partner Proskauer Rose

Stephanie Visioli Head, Medical Operations Novartis Pharmaceuticals

Heather Vital Associate Director, Marketing Biogen

Jason Vittitow Director of Clinical Affairs Valeant

Emily Vlasak Director, Corporate Communications Alexion Pharmaceuticals

Viviana Volta Postdoc New York University School of Medicine Alexander von Perfall Vice President, Investor Relations & Public Affairs Royalty Pharma

Alexandra von Plato Global Group President Publicis Health

Jacky Vonderscher Vice President Corporate Development & Strategy Enyo Pharma

Szilard Voros CEO G3 Therapeutics

Szilard Voros CEO Global Genomics Group

Michal Misha Votruba Director, Life Sciences, MD RSJ Investments

Michel Vounatsos CEO Biogen

Christel Wagner Development Manager, R&D J&J

Sam Waksal CEO Waksal Group

Wade Walke Vice President of Corporate Communications Ionis Pharmaceuticals

Marta Walker

Matt Wallach Co-Founder & President Veeva

Jeff Wallerstein CEO New York Stem Cell Foundation

Brian Walsh Senior Director, Business Development Aptuit

Kayla Walsh Editorial | Circulation | Awards Coordinator PM360

Sihong Wang Associate Professor CUNY City College

Zhongmin Wang PhD Student Gerstner Sloan Kettering Graduate School

Viktoria Wang Co-Founder & CEO Helicity Technologies

Robert Ward Founder Adventure Capitalist

Del Warmington Managing Partner Delwar Capital

Kristi Warner Senior Manager, Heart Failure Public Affairs Abbott

Stanford Warshawsky CEO Bismarck Capital Llc

Kaja Wasik Chief Scientific Officer Gencove

Alex Wathen Marketing Psocratic

Crystal Watson Rare TA Lead, Value & Access Biogen

Mark Watson Managing Director MW Associates International

Ryan Watts CEO Denali Therapeutics

Michael Weamer President & CEO The Marfan Foundation

Tom Wegman President BioSpecifics Technologies

Lan Wei Medical Strategy for Viral Hepatitis Bristol-Myers Squibb

Marc Weinberg Senior Consulting Practice Manager Oracle Health Sciences

David Weinreich Senior Vice President Global Clinical Development Regeneron Pharmaceuticals, Inc.

Steven Weiss Director Fairfield Research

Jonathan Weiss Senior Scientist Kadmon Corporation, LLC

Stanley H. Weiss Professor Rutgers New Jersey Medical School

Larissa Wenning Quantitative Sciences Merck & Co., Inc.

Lawrence Wennogle Vice President Drug Discovery Intra-Cellular Therapies, Inc.

Michelle Werner Head, US Hematology Marketing AstraZeneca

Carol Ann Werther Managing Director & Senior Healthcare Analyst H.C. Wainwright & Co, LLC, Research Division

Paul Wes Director Pfizer, Inc.

Camilla White Director FTI Consulting

Richard White Assistant Member Memorial Sloan Kettering Cancer Center

Steve Whitehead Senior Associate Scientist, Laboratory of Infectious National Institute for Allergies & Infectious Diseases Disease, NIH

Marion Wiesel Elie Wiesel Foundation

Sherman Williams Investment Banking Chardan

Constance Williams Manager New York University

Sharon Williams Visual Analytics Manager Roche TCRC, Inc.

M. Paui Williamson Novartis Pharmaceuticals

Laura Winchester Senior Account Executive Finn Partners

Aaron Windfield Co-Founder Psocratic

Warren Winkelman Senior Medical Director Nestle Skin Health

Hannah Wise Graduate Student Memorial Sloan Kettering Cancer Center

Lisa Wisniewski President S3B

Nancy Witty CEO ISSCR

Amanda Woerman Assistant Professor, Institute for Neurodegenerative University of California San Francisco Diseases

Matt Woerman Researcher University of California, Berkeley

BiSeniorat Woldemichael Postdoctoral fellow Mount Sinai Hospital

Michael Wolf Chief Revenue Officer Rejuvenan Global Health

Joanna Wolkowski Vice President, Portfolio & Decision Analysis Pfizer, Inc.

Garrett Wong Data Analyst Icahn School of Medicine at Mount Sinai

Linda Wong Director New York University Hospital

Richard Woodman Senior Vice President, US Oncology CDMA Novartis Pharmaceuticals

Brittany Woods Graduate Student Memorial Sloan Kettering Cancer Center

Hamish Wright Director, BD&L Merck

Wenjue Wu Co Founder Global Healthcare Drinks

Qian Wu Assistant Research Scientist New York University School of Medicine

Artur Wysoczanski Medical Student Columbia University College of Physicians & Surgeons Anton Xavier Oncology R&D & External Sciences & Innovation Pfizer, Inc.

Ruobing Xia President Life Science Quest

Qing Xiang Senior Principal Scientist, Functional Genomics, Pfizer, Inc. Genome Sciences & Technologies

Jennifer Xiong Production Manager East River BioSolutions

Emma Xu CEO A&Z Pharmaceutical

Steven Xu Scientific Director J&J

Jane Xu Head, Global Data Science Sunovion Pharmaceuticals, Inc.

Jane Xu Head, Global Data Science Sunovion Pharmaceuticals, Inc.

Jun Xu Executive Director The Leukemia & Lymphoma Society

Laura Xu

George Yancopoulos Chief Scientific Officer & President Regeneron Pharma & Regeneron Laboratories

Michael Yang Executive Vice President & Chief Commercial Officer ACADIA Pharmaceuticals Inc

Allen Yang Vice President, Therapeutic Area Head, Hematology- Jazz Pharmaceuticals Oncology

Tanya Yankelevich Director, Business Development East River BioSolutions, Inc.

Ehsan Yazdi Founder & CEO NomoCan Pharmaceuticals

Elaine Yeomans Managing Partner Partners in Pharma LLC

Michael Yeomans President Partners in Pharma LLC

Gokce Yildirim MBA Candidate Columbia Business School Jonathan Yong Senior Director, Global Medical SMA Biogen

Larry Yost US General Manager Integragen

James Youakim Vice President, Clinical Development ACADIA Pharmaceuticals Inc

Peter Young President Young and Partners Investment Advisors

Jonathan Yu Senior Account manager W2

Rex Yung Chief Scientific Officer ProLung

Nevin Yusufova PhD Student Weill Cornell Medicine

Emmanuel Zachariah President & CEO OncoPath Genomics, Inc

Sakellarios Zairis Chief Scientist Beagle Bioscience

Alexandra Zanin-Zhorov Vice President, Head of Immunology Kadmon Corporation, LLC

Brett Zbar Managing Director Foresite Capital Management LLC

Dagnia Zeidlickis Vice President Communications CSHL

Benjamin Zeskind CEO Immuneering Corporation

Jian Zhang Partner BoJian Capital

Jingya Zhang Senior Scientist Kadmon Corporation, LLC

Peter Zhang Senior Director, Pharmaceutical Development & Otsuka Commercialization

Steven Zhang Global Franchise Medical Lead, Ophthalmics Shire

John Zhong Senior Director, Biostatistics Biogen

Sherie Zhou MBA Student Columbia Business School

Yun-Ping Zhou Global Director, Sci Med Patient Perspective Merck & Co., Inc

Jen Zimmons President Zimmons International

Margaret Zittel Merck & Co., Inc.

Gal Zohar Self Galz

Anita Zubak Executive Director, Global Development IT Merck & Co., Inc.

John Zumbo Vice President GXZ Capital Investment

Lynne Zydowsky President & Co-Founder, Alexandria Summit; Chief Alexandria Real Estate Equities, Inc./Alexandria Science Advisor to the CEO Venture Investments